Module:EURMP/data
MyWikiBiz, Author Your Legacy — Monday January 13, 2025
Jump to navigationJump to searchDocumentation for this module may be created at Module:EURMP/data/doc
-- Data for European Union Register of medicinal products for human use
-- Module:EURMP/data
-- Exports array
-- Exports array
-- Licence = Creative Commons Attribution 4.0 International (CC BY 4.0)
-- Author = European Union
-- Source = https://ec.europa.eu/health/documents/community-register/html/reg_hum_act.htm
-- Changes =
-- "EU #", "Brand name", "Marketing Authorisation Holder"
local eurmpdata = {
{"EU/1/21/1529", "COVID-19 Vaccine AstraZeneca", "AstraZeneca AB"},
{"EU/1/20/1528", "Comirnaty", "BioNTech Manufacturing GmbH"},
{"EU/1/20/1508", "Enhertu", "Daiichi Sankyo Europe GmbH"},
{"EU/1/20/1507", "COVID-19 Vaccine Moderna", "MODERNA BIOTECH SPAIN, S.L."},
{"EU/1/20/1504", "ELZONRIS", "Stemline Therapeutics B.V."},
{"EU/1/20/1502", "Roclanda", "Aerie Pharmaceuticals Ireland Ltd"},
{"EU/1/20/1500", "Xofluza", "Roche Registration GmbH"},
{"EU/1/20/1499", "Onbevzi", "Samsung Bioepis NL B.V."},
{"EU/1/20/1498", "TRIXEO AEROSPHERE", "AstraZeneca AB"},
{"EU/1/20/1497", "Phesgo", "Roche Registration GmbH"},
{"EU/1/20/1496", "Oxlumo", "Alnylam Netherlands B.V."},
{"EU/1/20/1495", "Palforzia", "Aimmune Therapeutics Ireland Limited"},
{"EU/1/20/1494", "Leqvio", "Novartis Europharm Limited"},
{"EU/1/20/1493", "Libmeldy", "Orchard Therapeutics (Netherlands) B.V."},
{"EU/1/20/1492", "Tecartus", "Kite Pharma EU B.V."},
{"EU/1/20/1491", "Fintepla", "Zogenix ROI Limited"},
{"EU/1/20/1490", "Lenalidomide Mylan", "Mylan Ireland Limited"},
{"EU/1/20/1489", "EXPAREL liposomal", "Pacira Ireland Ltd"},
{"EU/1/20/1488", "Rivaroxaban Accord", "Accord Healthcare S.L.U."},
{"EU/1/20/1487", "PHELINUN", "ADIENNE S.r.l.S.U."},
{"EU/1/20/1486", "Nyvepria", "Pfizer Europe MA EEIG"},
{"EU/1/20/1485", "Obiltoxaximab SFL", "SFL Pharmaceuticals Deutschland GmbH"},
{"EU/1/20/1484", "Supemtek", "Sanofi Pasteur"},
{"EU/1/20/1483", "MenQuadfi", "Sanofi Pasteur"},
{"EU/1/20/1482", "REKAMBYS", "Janssen-Cilag International NV"},
{"EU/1/20/1481", "Vocabria", "ViiV Healthcare BV"},
{"EU/1/20/1480", "Jyseleca", "Gilead Sciences Ireland UC"},
{"EU/1/20/1479", "Calquence", "AstraZeneca AB"},
{"EU/1/20/1478", "Zynrelef", "Heron Therapeutics, B.V."},
{"EU/1/20/1477", "Fampridine Accord", "Accord Healthcare S.L.U."},
{"EU/1/20/1476", "Adakveo", "Novartis Europharm Limited"},
{"EU/1/20/1475", "Arsenic trioxide medac", "medac Gesellschaft für klinische Spezialpräparate mbH"},
{"EU/1/20/1474", "BLENREP", "GlaxoSmithKline (Ireland) Limited"},
{"EU/1/20/1473", "AYVAKYT", "Blueprint Medicines (Netherlands) B.V."},
{"EU/1/20/1472", "Equidacent", "Centus Biotherapeutics Europe Limited"},
{"EU/1/20/1471", "Idefirix", "Hansa Biopharma AB"},
{"EU/1/20/1470", "Lumeblue", "Cosmo Technologies Ltd"},
{"EU/1/20/1469", "ARIKAYCE liposomal", "Insmed Netherlands B.V."},
{"EU/1/20/1468", "Kaftrio", "Vertex Pharmaceuticals (Ireland) Limited"},
{"EU/1/20/1465", "Gencebok", "Gennisium Pharma"},
{"EU/1/20/1462", "Livogiva", "Theramex Ireland Limited"},
{"EU/1/20/1460", "Rozlytrek", "Roche Registration GmbH"},
{"EU/1/20/1459", "Veklury", "Gilead Sciences Ireland UC"},
{"EU/1/20/1458", "Apixaban Accord", "Accord Healthcare S.L.U."},
{"EU/1/20/1457", "Xenleta", "Nabriva Therapeutics Ireland DAC"},
{"EU/1/20/1456", "Zercepac", "Accord Healthcare S.L.U."},
{"EU/1/20/1455", "Piqray", "Novartis Europharm Limited"},
{"EU/1/20/1454", "Aybintio", "Samsung Bioepis NL B.V."},
{"EU/1/20/1453", "Paliperidone Janssen-Cilag International", "Janssen-Cilag International NV"},
{"EU/1/20/1452", "Reblozyl", "Celgene Europe B.V."},
{"EU/1/20/1451", "Daurismo", "Pfizer Europe MA EEIG"},
{"EU/1/20/1450", "Fingolimod Accord", "Accord Healthcare S.L.U."},
{"EU/1/20/1448", "Cabazitaxel Accord", "Accord Healthcare S.L.U."},
{"EU/1/20/1447", "Insulin aspart Sanofi", "Sanofi-Aventis groupe"},
{"EU/1/20/1446", "Hepcludex", "Myr GmbH"},
{"EU/1/20/1445", "Mvabea", "Janssen-Cilag International NV"},
{"EU/1/20/1444", "Zabdeno", "Janssen-Cilag International NV"},
{"EU/1/20/1443", "Zolgensma", "Novartis Gene Therapies EU Limited"},
{"EU/1/20/1442", "Zeposia", "Bristol-Myers Squibb Pharma EEIG"},
{"EU/1/20/1441", "Bemrist Breezhaler", "Novartis Europharm Limited"},
{"EU/1/20/1440", "Zimbus Breezhaler", "Novartis Europharm Limited"},
{"EU/1/20/1439", "Atectura Breezhaler", "Novartis Europharm Limited"},
{"EU/1/20/1438", "Enerzair Breezhaler", "Novartis Europharm Limited"},
{"EU/1/20/1437", "Dovprela", "Mylan IRE Healthcare Limited"},
{"EU/1/20/1436", "Nepexto", "Mylan IRE Healthcare Limited"},
{"EU/1/20/1435", "Sarclisa", "Sanofi-Aventis groupe"},
{"EU/1/20/1434", "Fetcroja", "Shionogi B.V."},
{"EU/1/20/1433", "Fluad Tetra", "Seqirus Netherlands B.V."},
{"EU/1/20/1432", "NUBEQA", "Bayer AG"},
{"EU/1/20/1431", "Ruxience", "Pfizer Europe MA EEIG"},
{"EU/1/20/1430", "Rybelsus", "Novo Nordisk A/S"},
{"EU/1/20/1429", "Cinacalcet Accordpharma", "Accord Healthcare S.L.U."},
{"EU/1/20/1428", "Givlaari", "Alnylam Netherlands B.V."},
{"EU/1/20/1427", "Arsenic trioxide Mylan", "Mylan Ireland Limited"},
{"EU/1/20/1426", "Azacitidine Mylan", "Mylan Ireland Limited"},
{"EU/1/20/1425", "Nilemdo", "Daiichi Sankyo Europe GmbH"},
{"EU/1/20/1424", "Nustendi", "Daiichi Sankyo Europe GmbH"},
{"EU/1/20/1423", "Vaxchora", "Emergent Netherlands B.V."},
{"EU/1/20/1422", "Lyumjev", "Eli Lilly Nederland B.V."},
{"EU/1/19/1421", "Staquis", "Pfizer Europe MA EEIG"},
{"EU/1/19/1420", "Recarbrio", "Merck Sharp & Dohme B.V."},
{"EU/1/19/1419", "Trepulmix", "SciPharm Sàrl"},
{"EU/1/19/1418", "Dexmedetomidine Accord", "Accord Healthcare S.L.U."},
{"EU/1/19/1417", "Beovu", "Novartis Europharm Limited"},
{"EU/1/19/1416", "Azacitidine Betapharm", "betapharm Arzneimittel GmbH"},
{"EU/1/19/1415", "Amsparity", "Pfizer Europe MA EEIG"},
{"EU/1/19/1414", "Mayzent", "Novartis Europharm Limited"},
{"EU/1/19/1413", "Azacitidine Accord", "Accord Healthcare S.L.U."},
{"EU/1/19/1412", "Deferasirox Accord", "Accord Healthcare S.L.U."},
{"EU/1/19/1411", "Evenity", "UCB Pharma S.A."},
{"EU/1/19/1410", "Spravato", "Janssen-Cilag International NV"},
{"EU/1/19/1409", "Cegfila", "Mundipharma Corporation (Ireland) Limited"},
{"EU/1/19/1408", "Sunosi", "Jazz Pharmaceuticals Ireland Ltd"},
{"EU/1/19/1407", "Isturisa", "Recordati Rare Diseases"},
{"EU/1/19/1406", "Baqsimi", "Eli Lilly Nederland B.V."},
{"EU/1/19/1405", "TAVLESSE", "Instituto Grifols, S.A."},
{"EU/1/19/1404", "Rinvoq", "AbbVie Deutschland GmbH & Co. KG"},
{"EU/1/19/1403", "Budesonide/Formoterol Teva Pharma B.V.", "Teva Pharma B.V."},
{"EU/1/19/1400", "Rhokiinsa", "Aerie Pharmaceuticals Ireland Ltd"},
{"EU/1/19/1399", "Xospata", "Astellas Pharma Europe B.V."},
{"EU/1/19/1398", "Arsenic Trioxide Accord", "Accord Healthcare S.L.U."},
{"EU/1/19/1397", "Bortezomib Fresenius Kabi", "Fresenius Kabi Deutschland GmbH"},
{"EU/1/19/1396", "Ivozall", "ORPHELIA Pharma SAS"},
{"EU/1/19/1395", "Clopidogrel/Acetylsalicylic acid Mylan", "Mylan S.A.S."},
{"EU/1/19/1394", "Tigecycline Accord", "Accord Healthcare S.L.U."},
{"EU/1/19/1393", "Quofenix", "A. Menarini - Industrie Farmaceutiche Riunite - s.r.l."},
{"EU/1/19/1392", "Ervebo", "Merck Sharp & Dohme B.V."},
{"EU/1/19/1390", "Inbrija", "Acorda Therapeutics Ireland Limited"},
{"EU/1/19/1389", "Epidyolex", "GW Pharma (International) B.V."},
{"EU/1/19/1388", "Polivy", "Roche Registration GmbH"},
{"EU/1/19/1387", "Senstend", "Plethora Pharma Solutions Ltd."},
{"EU/1/19/1386", "Deferasirox Mylan", "Mylan S.A.S."},
{"EU/1/19/1385", "VITRAKVI", "Bayer AG"},
{"EU/1/19/1384", "Giapreza", "La Jolla Pharmaceutical II B.V."},
{"EU/1/19/1383", "Lacosamide UCB", "UCB Pharma S.A."},
{"EU/1/19/1382", "Azacitidine Celgene", "Celgene Europe B.V."},
{"EU/1/19/1381", "LysaKare", "Advanced Accelerator Applications"},
{"EU/1/19/1380", "Posaconazole AHCL", "Accord Healthcare S.L.U."},
{"EU/1/19/1379", "Posaconazole Accord", "Accord Healthcare S.L.U."},
{"EU/1/19/1378", "Temybric Ellipta", "GlaxoSmithKline Trading Services Limited"},
{"EU/1/19/1377", "Talzenna", "Pfizer Europe MA EEIG"},
{"EU/1/19/1376", "LIBTAYO", "Regeneron Ireland Designated Activity Company (DAC)"},
{"EU/1/19/1375", "Grasustek", "Juta Pharma GmbH"},
{"EU/1/19/1374", "Esperoct", "Novo Nordisk A/S"},
{"EU/1/19/1373", "Doptelet", "Swedish Orphan Biovitrum AB (publ)"},
{"EU/1/19/1372", "Striascan", "CIS bio international"},
{"EU/1/19/1371", "Ultomiris", "Alexion Europe SAS"},
{"EU/1/19/1370", "Dovato", "ViiV Healthcare B.V."},
{"EU/1/19/1369", "Sixmo", "L. Molteni & C. dei F.lli Alitti Soc.Es.S.p.A"},
{"EU/1/19/1368", "Ambrisentan Mylan", "Mylan S.A.S."},
{"EU/1/19/1367", "Zynteglo", "bluebird bio (Netherlands) B.V."},
{"EU/1/19/1366", "Xromi", "Nova Laboratories Ireland Limited"},
{"EU/1/19/1365", "Cufence", "Univar Solutions B.V."},
{"EU/1/19/1364", "NUCEIVA", "Evolus Pharma Limited"},
{"EU/1/19/1363", "Zynquista", "Guidehouse Germany GmbH"},
{"EU/1/19/1362", "Palynziq", "BioMarin International Limited"},
{"EU/1/19/1361", "Skyrizi", "AbbVie Deutschland GmbH & Co. KG"},
{"EU/1/19/1360", "Waylivra", "Akcea Therapeutics Ireland Limited"},
{"EU/1/19/1359", "Trogarzo", "Theratechnologies Europe Limited"},
{"EU/1/19/1358", "AJOVY", "Teva GmbH"},
{"EU/1/19/1356", "Idacio", "Fresenius Kabi Deutschland GmbH"},
{"EU/1/19/1355", "Lorviqua", "Pfizer Europe MA EEIG"},
{"EU/1/19/1354", "Vizimpro", "Pfizer Europe MA EEIG"},
{"EU/1/19/1353", "Atazanavir Krka", "KRKA d d., Novo mesto"},
{"EU/1/18/1352", "Besremi", "AOP Orphan Pharmaceuticals AG"},
{"EU/1/18/1351", "Trecondi", "medac Gesellschaft für klinische Spezialpräparate mbH"},
{"EU/1/18/1350", "Tobramycin PARI", "PARI Pharma GmbH"},
{"EU/1/18/1349", "Dectova", "GlaxoSmithKline Trading Services Limited"},
{"EU/1/18/1348", "Mulpleo", "Shionogi B.V."},
{"EU/1/18/1347", "Febuxostat Krka", "KRKA d d., Novo mesto"},
{"EU/1/18/1346", "Miglustat Dipharma", "Dipharma B.V."},
{"EU/1/18/1345", "Ondexxya", "Alexion Europe SAS"},
{"EU/1/18/1344", "Zirabev", "Pfizer Europe MA EEIG"},
{"EU/1/18/1343", "Silodosin Recordati", "Recordati Ireland Ltd"},
{"EU/1/18/1342", "Erleada", "Janssen-Cilag International NV"},
{"EU/1/18/1341", "Ogivri", "Mylan S.A.S."},
{"EU/1/18/1340", "TAKHZYRO", "Shire Pharmaceuticals Ireland Limited"},
{"EU/1/18/1339", "Bevespi Aerosphere", "AstraZeneca AB"},
{"EU/1/18/1338", "Dengvaxia", "Sanofi Pasteur"},
{"EU/1/18/1337", "Macimorelin Aeterna Zentaris", "Æterna Zentaris GmbH"},
{"EU/1/18/1336", "Buvidal", "Camurus AB"},
{"EU/1/18/1335", "Poteligeo", "Kyowa Kirin Holdings B.V."},
{"EU/1/18/1334", "Vaborem", "Menarini International Operations Luxembourg S.A."},
{"EU/1/18/1333", "Delstrigo", "Merck Sharp & Dohme B.V."},
{"EU/1/18/1332", "Pifeltro", "Merck Sharp & Dohme B.V."},
{"EU/1/18/1331", "Luxturna", "Novartis Europharm Limited"},
{"EU/1/18/1330", "Emgality", "Eli Lilly Nederland B.V."},
{"EU/1/18/1329", "Fulphila", "Mylan S.A.S."},
{"EU/1/18/1328", "Pelmeg", "Mundipharma Corporation (Ireland) Limited"},
{"EU/1/18/1327", "Ziextenzo", "Sandoz GmbH"},
{"EU/1/18/1326", "Flucelvax Tetra", "Seqirus Netherlands B.V."},
{"EU/1/18/1325", "Namuscla", "Lupin Europe GmbH"},
{"EU/1/18/1324", "Jivi", "Bayer AG"},
{"EU/1/18/1323", "Ilumetri", "Almirall, S.A."},
{"EU/1/18/1322", "Imfinzi", "AstraZeneca AB"},
{"EU/1/18/1321", "Gefitinib Mylan", "Mylan S.A.S."},
{"EU/1/18/1320", "Onpattro", "Alnylam Netherlands B.V."},
{"EU/1/18/1319", "Hulio", "Mylan S.A.S."},
{"EU/1/18/1318", "Slenyto", "RAD Neurim Pharmaceuticals EEC SARL"},
{"EU/1/18/1317", "Pazenir", "ratiopharm GmbH"},
{"EU/1/18/1316", "Lenalidomide Accord", "Accord Healthcare S.L.U."},
{"EU/1/18/1315", "Mektovi", "Pierre Fabre Médicament"},
{"EU/1/18/1314", "Braftovi", "Pierre Fabre Médicament"},
{"EU/1/18/1313", "Pelgraz", "Accord Healthcare S.L.U."},
{"EU/1/18/1312", "Xerava", "Tetraphase Pharmaceuticals Ireland Limited"},
{"EU/1/18/1311", "Nerlynx", "Pierre Fabre Médicament"},
{"EU/1/18/1310", "Deferiprone Lipomed", "Lipomed GmbH"},
{"EU/1/18/1309", "Ulipristal Acetate Gedeon Richter", "Gedeon Richter Plc."},
{"EU/1/18/1308", "Vyxeos liposomal", "Jazz Pharmaceuticals Ireland Ltd"},
{"EU/1/18/1307", "Verzenios", "Eli Lilly Nederland B.V."},
{"EU/1/18/1306", "Symkevi", "Vertex Pharmaceuticals (Ireland) Limited"},
{"EU/1/18/1305", "Cablivi", "Ablynx N.V."},
{"EU/1/18/1303", "Udenyca", "ERA Consulting GmbH"},
{"EU/1/18/1302", "Kigabeq", "ORPHELIA Pharma SAS"},
{"EU/1/18/1301", "Mepsevii", "Ultragenyx Germany GmbH"},
{"EU/1/18/1299", "Yescarta", "Kite Pharma EU B.V."},
{"EU/1/18/1298", "VEYVONDI", "Baxalta Innovations GmbH"},
{"EU/1/18/1297", "Kymriah", "Novartis Europharm Limited"},
{"EU/1/18/1296", "Tegsedi", "Akcea Therapeutics Ireland Ltd"},
{"EU/1/18/1295", "Trazimera", "Pfizer Europe MA EEIG"},
{"EU/1/18/1294", "RXULTI", "Otsuka Pharmaceutical Netherlands B.V."},
{"EU/1/18/1293", "Aimovig", "Novartis Europharm Limited"},
{"EU/1/18/1292", "Apealea", "Oasmia Pharmaceutical AB"},
{"EU/1/18/1291", "Rizmoic", "Shionogi B.V."},
{"EU/1/18/1290", "Nityr", "Cycle Pharmaceuticals (Europe) Ltd"},
{"EU/1/18/1289", "Biktarvy", "Gilead Sciences Ireland UC"},
{"EU/1/18/1287", "Hefiya", "Sandoz GmbH"},
{"EU/1/18/1286", "Hyrimoz", "Sandoz GmbH"},
{"EU/1/18/1284", "Dzuveo", "FGK Representative Service GmbH"},
{"EU/1/18/1283", "Pemetrexed Krka", "KRKA, d.d."},
{"EU/1/18/1282", "Juluca", "ViiV Healthcare B.V."},
{"EU/1/18/1281", "KANJINTI", "Amgen Europe B.V."},
{"EU/1/18/1280", "Zessly", "Sandoz GmbH"},
{"EU/1/18/1279", "AMGLIDIA", "AMMTeK"},
{"EU/1/18/1278", "Carmustine Obvius", "Obvius Investment B.V."},
{"EU/1/18/1277", "Mylotarg", "Pfizer Europe MA EEIG"},
{"EU/1/18/1276", "Myalepta", "Amryt Pharmaceuticals DAC"},
{"EU/1/18/1275", "Riarify", "Chiesi Farmaceutici S.p.A."},
{"EU/1/18/1274", "Trydonis", "Chiesi Farmaceutici S.p.A."},
{"EU/1/18/1273", "Prasugrel Mylan", "Mylan S.A.S."},
{"EU/1/18/1272", "Shingrix", "GlaxoSmithKline Biologicals S.A."},
{"EU/1/18/1271", "Hemlibra", "Roche Registration GmbH"},
{"EU/1/18/1270", "Semglee", "Mylan S.A.S."},
{"EU/1/18/1269", "Alpivab", "BioCryst Ireland Limited"},
{"EU/1/18/1267", "Steglatro", "Merck Sharp & Dohme B.V."},
{"EU/1/18/1266", "Steglujan", "Merck Sharp & Dohme B.V."},
{"EU/1/18/1265", "Segluromet", "Merck Sharp & Dohme B.V."},
{"EU/1/18/1264", "Alunbrig", "Takeda Pharma A/S"},
{"EU/1/17/1263", "Efavirenz/Emtricitabine/Tenofovir disoproxil Krka", "KRKA d d., Novo mesto"},
{"EU/1/17/1262", "CRYSVITA", "Kyowa Kirin Holdings B.V."},
{"EU/1/17/1261", "Alofisel", "Takeda Pharma A/S"},
{"EU/1/17/1260", "Alkindi", "Diurnal Europe B.V."},
{"EU/1/17/1258", "Lamzede", "Chiesi Farmaceutici S.p.A."},
{"EU/1/17/1257", "Herzuma", "Celltrion Healthcare Hungary Kft."},
{"EU/1/17/1256", "Anagrelide Mylan", "Mylan S.A.S."},
{"EU/1/17/1255", "Intrarosa", "Endoceutics S.A."},
{"EU/1/17/1254", "Jorveza", "Dr Falk Pharma GmbH"},
{"EU/1/17/1253", "Fulvestrant Mylan", "Mylan S.A.S."},
{"EU/1/17/1252", "Fasenra", "AstraZeneca AB"},
{"EU/1/17/1251", "Ozempic", "Novo Nordisk A/S"},
{"EU/1/17/1250", "Rubraca", "Clovis Oncology Ireland Limited"},
{"EU/1/17/1249", "Darunavir Krka", "KRKA d d., Novo mesto"},
{"EU/1/17/1248", "Darunavir Krka d.d.", "KRKA d d., Novo mesto"},
{"EU/1/17/1247", "ADYNOVI", "Baxalta Innovations GmbH"},
{"EU/1/17/1246", "Mvasi", "Amgen Technology (Ireland) UC"},
{"EU/1/17/1245", "PREVYMIS", "Merck Sharp & Dohme B.V."},
{"EU/1/17/1244", "Tacforius", "Teva B.V."},
{"EU/1/17/1242", "Ritonavir Mylan", "Mylan S.A.S."},
{"EU/1/17/1241", "Ontruzant", "Samsung Bioepis NL B.V."},
{"EU/1/17/1239", "VeraSeal", "Instituto Grifols, S.A."},
{"EU/1/17/1238", "Nyxoid", "Mundipharma Corporation (Ireland) Limited"},
{"EU/1/17/1237", "Elebrato Ellipta", "GlaxoSmithKline Trading Services Limited"},
{"EU/1/17/1236", "Trelegy Ellipta", "GlaxoSmithKline Trading Services Limited"},
{"EU/1/17/1235", "Zejula", "GlaxoSmithKline (Ireland) Limited"},
{"EU/1/17/1234", "Tremfya", "Janssen-Cilag International NV"},
{"EU/1/17/1233", "Zubsolv", "Orexo AB"},
{"EU/1/17/1232", "Miglustat Gen.Orph", "Gen.Orph"},
{"EU/1/17/1231", "Ocrevus", "Roche Registration GmbH"},
{"EU/1/17/1230", "Lacosamide Accord", "Accord Healthcare S.L.U."},
{"EU/1/17/1229", "Dupixent", "Sanofi-Aventis groupe"},
{"EU/1/17/1228", "TOOKAD", "Steba Biotech S.A"},
{"EU/1/17/1227", "Entecavir Mylan", "Mylan S.A.S."},
{"EU/1/17/1226", "Lutathera", "Advanced Accelerator Applications"},
{"EU/1/17/1225", "Symtuza", "Janssen-Cilag International NV"},
{"EU/1/17/1224", "Xermelo", "Ipsen Pharma"},
{"EU/1/17/1223", "Vosevi", "Gilead Sciences Ireland UC"},
{"EU/1/17/1222", "Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan", "Mylan S.A.S."},
{"EU/1/17/1221", "Kisqali", "Novartis Europharm Limited"},
{"EU/1/17/1220", "Tecentriq", "Roche Registration GmbH"},
{"EU/1/17/1219", "Verkazia", "Santen Oy"},
{"EU/1/17/1218", "Rydapt", "Novartis Europharm Limited"},
{"EU/1/17/1217", "Nitisinone MDK", "MendeliKABS Europe Limited"},
{"EU/1/17/1216", "Imraldi", "Samsung Bioepis NL B.V."},
{"EU/1/17/1215", "Fotivda", "EUSA Pharma (Netherlands) B.V."},
{"EU/1/17/1214", "Bavencio", "Merck Europe B.V."},
{"EU/1/17/1213", "Maviret", "AbbVie Deutschland GmbH & Co. KG"},
{"EU/1/17/1212", "MAVENCLAD", "Merck Europe B.V."},
{"EU/1/17/1211", "Entecavir Accord", "Accord Healthcare S.L.U."},
{"EU/1/17/1210", "Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva", "Zentiva, k.s."},
{"EU/1/17/1209", "Reagila", "Gedeon Richter Plc."},
{"EU/1/17/1208", "Trimbow", "Chiesi Farmaceutici S.p.A."},
{"EU/1/17/1207", "Ritemvia", "Celltrion Healthcare Hungary Kft."},
{"EU/1/17/1205", "Blitzima", "Celltrion Healthcare Hungary Kft."},
{"EU/1/17/1203", "Insulin lispro Sanofi", "Sanofi-Aventis groupe"},
{"EU/1/17/1202", "Ucedane", "Eurocept International B.V."},
{"EU/1/17/1201", "Skilarence", "Almirall, S.A."},
{"EU/1/17/1200", "Besponsa", "Pfizer Europe MA EEIG"},
{"EU/1/17/1199", "Cuprior", "Orphalan"},
{"EU/1/17/1197", "OXERVATE", "Dompé farmaceutici S.p.A."},
{"EU/1/17/1196", "Kevzara", "Sanofi-Aventis groupe"},
{"EU/1/17/1195", "Erelzi", "Sandoz GmbH"},
{"EU/1/17/1194", "Febuxostat Mylan", "Mylan S.A.S."},
{"EU/1/17/1193", "Refixia", "Novo Nordisk A/S"},
{"EU/1/17/1192", "Brineura", "BioMarin International Limited"},
{"EU/1/17/1191", "Qarziba", "EUSA Pharma (Netherlands) B.V."},
{"EU/1/17/1190", "Ivabradine Accord", "Accord Healthcare S.L.U."},
{"EU/1/17/1189", "Elmiron", "bene-Arzneimittel GmbH"},
{"EU/1/17/1188", "Spinraza", "Biogen Netherlands B.V."},
{"EU/1/17/1187", "Trumenba", "Pfizer Europe MA EEIG"},
{"EU/1/17/1186", "Axumin", "Blue Earth Diagnostics Ireland Ltd"},
{"EU/1/17/1185", "Rixathon", "Sandoz GmbH"},
{"EU/1/17/1184", "Riximyo", "Sandoz GmbH"},
{"EU/1/17/1183", "Pemetrexed Pfizer", "Pfizer Europe MA EEIG"},
{"EU/1/17/1182", "Emtricitabine /Tenofovir disoproxil Krka d.d.", "KRKA d d., Novo mesto"},
{"EU/1/17/1181", "Spherox", "CO.DON AG"},
{"EU/1/17/1179", "Veltassa", "Vifor Fresenius Medical Care Renal Pharma France"},
{"EU/1/17/1178", "Xeljanz", "Pfizer Europe MA EEIG"},
{"EU/1/17/1177", "Tadalafil Lilly", "Eli Lilly Nederland B.V."},
{"EU/1/17/1176", "Yargesa", "Piramal Critical Care B.V."},
{"EU/1/17/1175", "Daptomycin Hospira", "Pfizer Europe MA EEIG"},
{"EU/1/17/1174", "Rolufta Ellipta", "GlaxoSmithKline Trading Services Limited"},
{"EU/1/17/1173", "Lokelma", "AstraZeneca AB"},
{"EU/1/17/1172", "Jylamvo", "Therakind (Europe) Limited"},
{"EU/1/16/1171", "Ledaga", "Helsinn Birex Pharmaceuticals Ltd."},
{"EU/1/16/1170", "Olumiant", "Eli Lilly Nederland B.V."},
{"EU/1/16/1169", "Alecensa", "Roche Registration GmbH"},
{"EU/1/16/1168", "Vihuma", "Octapharma AB"},
{"EU/1/16/1167", "Truxima", "Celltrion Healthcare Hungary Kft."},
{"EU/1/16/1166", "Pregabalin Zentiva k.s", "Zentiva, k.s."},
{"EU/1/16/1164", "AMGEVITA", "Amgen Europe B.V."},
{"EU/1/16/1161", "Movymia", "STADA Arzneimittel AG"},
{"EU/1/16/1160", "Fiasp", "Novo Nordisk A/S"},
{"EU/1/16/1159", "Terrosa", "Gedeon Richter Plc."},
{"EU/1/16/1158", "AFSTYLA", "CSL Behring GmbH"},
{"EU/1/16/1157", "Suliqua", "Sanofi-Aventis groupe"},
{"EU/1/16/1156", "ZINPLAVA", "Merck Sharp & Dohme B.V."},
{"EU/1/16/1155", "Kyntheum", "Leo Pharma A/S"},
{"EU/1/16/1154", "Vemlidy", "Gilead Sciences Ireland UC"},
{"EU/1/16/1153", "Talmanco", "Mylan S.A.S."},
{"EU/1/16/1152", "Roteas", "Berlin-Chemie AG"},
{"EU/1/16/1151", "Emtricitabine/Tenofovir disoproxil Krka", "KRKA d d., Novo mesto"},
{"EU/1/16/1150", "Rekovelle", "Ferring Pharmaceuticals A/S"},
{"EU/1/16/1148", "Emtricitabine/Tenofovir disoproxil Zentiva", "Zentiva, k.s."},
{"EU/1/16/1147", "IBRANCE", "Pfizer Europe MA EEIG"},
{"EU/1/16/1146", "Glyxambi", "Boehringer Ingelheim International GmbH"},
{"EU/1/16/1144", "Ivabradine Zentiva", "Zentiva, k.s."},
{"EU/1/16/1142", "Parsabiv", "Amgen Europe B.V."},
{"EU/1/16/1141", "SomaKit TOC", "Advanced Accelerator Applications"},
{"EU/1/16/1140", "Darunavir Mylan", "Mylan S.A.S."},
{"EU/1/16/1139", "Ocaliva", "Intercept Pharma International Limited"},
{"EU/1/16/1138", "Venclyxto", "AbbVie Deutschland GmbH & Co. KG"},
{"EU/1/16/1137", "Granpidam", "Accord Healthcare S.L.U."},
{"EU/1/16/1136", "CABOMETYX", "Ipsen Pharma"},
{"EU/1/16/1135", "Sialanar", "Proveca Pharma Limited"},
{"EU/1/16/1134", "Mysildecard", "Mylan S.A.S."},
{"EU/1/16/1133", "Emtricitabine/Tenofovir disoproxil Mylan", "Mylan S.A.S."},
{"EU/1/16/1132", "Inhixa", "Techdow Pharma Netherlands B.V."},
{"EU/1/16/1130", "Onivyde pegylated liposomal", "Les Laboratoires Servier"},
{"EU/1/16/1129", "Tenofovir disoproxil Mylan", "Mylan S.A.S."},
{"EU/1/16/1128", "Kisplyx", "Eisai GmbH"},
{"EU/1/16/1127", "Tenofovir disoproxil Zentiva", "Zentiva, k.s."},
{"EU/1/16/1125", "Cinqaero", "Teva B.V."},
{"EU/1/16/1124", "Nordimet", "Nordic Group B.V."},
{"EU/1/16/1119", "Zepatier", "Merck Sharp & Dohme B.V."},
{"EU/1/16/1116", "Epclusa", "Gilead Sciences Ireland UC"},
{"EU/1/16/1115", "Pemetrexed Fresenius Kabi", "Fresenius Kabi Deutschland GmbH"},
{"EU/1/16/1114", "Bortezomib Hospira", "Pfizer Europe MA EEIG"},
{"EU/1/16/1112", "Odefsey", "Gilead Sciences Ireland UC"},
{"EU/1/16/1110", "Chenodeoxycholic acid Leadiant", "Leadiant GmbH"},
{"EU/1/16/1109", "Zavicefta", "Pfizer Ireland Pharmaceuticals"},
{"EU/1/16/1108", "Qtern", "AstraZeneca AB"},
{"EU/1/16/1106", "Flixabi", "Samsung Bioepis NL B.V."},
{"EU/1/16/1105", "EndolucinBeta", "ITM Medical Isotopes GmbH"},
{"EU/1/16/1104", "Palonosetron Accord", "Accord Healthcare S.L.U."},
{"EU/1/16/1103", "Neparvis", "Novartis Europharm Limited"},
{"EU/1/16/1102", "Bortezomib SUN", "Sun Pharmaceutical Industries Europe BV"},
{"EU/1/16/1101", "Darzalex", "Janssen-Cilag International NV"},
{"EU/1/16/1099", "Descovy", "Gilead Sciences Ireland UC"},
{"EU/1/16/1098", "ALPROLIX", "Swedish Orphan Biovitrum AB (publ)"},
{"EU/1/16/1097", "Strimvelis", "Orchard Therapeutics (Netherlands) B.V."},
{"EU/1/16/1096", "Lonsurf", "Les Laboratoires Servier"},
{"EU/1/16/1095", "IDELVION", "CSL Behring GmbH"},
{"EU/1/16/1094", "Ninlaro", "Takeda Pharma A/S"},
{"EU/1/16/1093", "Zonisamide Mylan", "Mylan S.A.S."},
{"EU/1/16/1092", "Amlodipine/Valsartan Mylan", "Mylan S.A.S."},
{"EU/1/16/1091", "Atazanavir Mylan", "Mylan S.A.S."},
{"EU/1/16/1090", "Rasagiline Mylan", "Mylan S.A.S."},
{"EU/1/16/1089", "Pandemic influenza vaccine H5N1 AstraZeneca", "AstraZeneca AB"},
{"EU/1/16/1088", "Empliciti", "Bristol-Myers Squibb Pharma EEIG"},
{"EU/1/16/1087", "Coagadex", "BPL Bioproducts Laboratory GmbH"},
{"EU/1/16/1086", "TAGRISSO", "AstraZeneca AB"},
{"EU/1/15/1085", "Taltz", "Eli Lilly Nederland B.V."},
{"EU/1/15/1084", "Portrazza", "Eli Lilly Nederland B.V."},
{"EU/1/15/1083", "Uptravi", "Janssen-Cilag International NV"},
{"EU/1/15/1082", "Galafold", "Amicus Therapeutics Europe Limited"},
{"EU/1/15/1079", "Vaxelis", "MCM Vaccine B.V."},
{"EU/1/15/1078", "Natpar", "Shire Pharmaceuticals Ireland Limited"},
{"EU/1/15/1076", "Kovaltry", "Bayer AG"},
{"EU/1/15/1075", "Feraccru", "Norgine B.V."},
{"EU/1/15/1074", "Benepali", "Samsung Bioepis NL B.V."},
{"EU/1/15/1073", "Briviact", "UCB Pharma S.A."},
{"EU/1/15/1072", "Spectrila", "medac Gesellschaft für klinische Spezialpräparate mbH"},
{"EU/1/15/1071", "Pemetrexed Accord", "Accord Healthcare S.L.U."},
{"EU/1/15/1070", "Oncaspar", "Les Laboratoires Servier"},
{"EU/1/15/1069", "Episalvan", "Amryt GMBH"},
{"EU/1/15/1068", "Wakix", "Bioprojet Pharma"},
{"EU/1/15/1067", "Lopinavir/Ritonavir Mylan", "Mylan S.A.S."},
{"EU/1/15/1066", "Ongentys", "Bial - Portela & Cª, SA"},
{"EU/1/15/1065", "Eptifibatide Accord", "Accord Healthcare S.L.U."},
{"EU/1/15/1064", "Imlygic", "Amgen Europe B.V."},
{"EU/1/15/1063", "Armisarte", "Actavis Group PTC ehf."},
{"EU/1/15/1062", "Ravicti", "Immedica Pharma AB"},
{"EU/1/15/1061", "Genvoya", "Gilead Sciences Ireland UC"},
{"EU/1/15/1060", "Kyprolis", "Amgen Europe B.V."},
{"EU/1/15/1059", "Orkambi", "Vertex Pharmaceuticals (Ireland) Limited"},
{"EU/1/15/1058", "Entresto", "Novartis Europharm Limited"},
{"EU/1/15/1057", "Pemetrexed Hospira", "Pfizer Europe MA EEIG"},
{"EU/1/15/1056", "Praxbind", "Boehringer Ingelheim International GmbH"},
{"EU/1/15/1055", "Ciambra", "Menarini International Operations Luxembourg S.A."},
{"EU/1/15/1054", "Cinacalcet Mylan", "Mylan S.A.S."},
{"EU/1/15/1053", "Neofordex", "Laboratoires CTRS"},
{"EU/1/15/1052", "Edistride", "AstraZeneca AB"},
{"EU/1/15/1051", "Ebymect", "AstraZeneca AB"},
{"EU/1/15/1049", "Cystadrops", "Recordati Rare Diseases"},
{"EU/1/15/1048", "Cotellic", "Roche Registration GmbH"},
{"EU/1/15/1047", "BLINCYTO", "Amgen Europe B.V."},
{"EU/1/15/1046", "Elocta", "Swedish Orphan Biovitrum AB (publ)"},
{"EU/1/15/1045", "Aripiprazole Accord", "Accord Healthcare S.L.U."},
{"EU/1/15/1043", "Nucala", "GlaxoSmithKline Trading Services Limited"},
{"EU/1/15/1042", "Zalviso", "Grünenthal GmbH"},
{"EU/1/15/1041", "Ivabradine Anpharm", "ANPHARM Przedsi?biorstwo Farmaceutyczne S.A."},
{"EU/1/15/1040", "Intuniv", "Shire Pharmaceuticals Ireland Limited"},
{"EU/1/15/1038", "Pemetrexed medac", "medac Gesellschaft für klinische Spezialpräparate mbH"},
{"EU/1/15/1037", "Pemetrexed Sandoz", "Sandoz GmbH"},
{"EU/1/15/1036", "Cresemba", "Basilea Pharmaceutica Deutschland GmbH"},
{"EU/1/15/1035", "Obizur", "Baxalta Innovations GmbH"},
{"EU/1/15/1034", "Pemetrexed Lilly", "Eli Lilly Nederland B.V."},
{"EU/1/15/1033", "Kanuma", "Alexion Europe SAS"},
{"EU/1/15/1032", "Zerbaxa", "Merck Sharp & Dohme B.V."},
{"EU/1/15/1031", "Praluent", "Sanofi-Aventis groupe"},
{"EU/1/15/1030", "Odomzo", "Sun Pharmaceutical Industries Europe BV"},
{"EU/1/15/1029", "Aripiprazole Sandoz", "Sandoz GmbH"},
{"EU/1/15/1028", "Duloxetine Zentiva", "Zentiva, k.s."},
{"EU/1/15/1027", "Pregabalin Accord", "Accord Healthcare S.L.U."},
{"EU/1/15/1025", "EVOTAZ", "Bristol-Myers Squibb/Pfizer EEIG"},
{"EU/1/15/1024", "KEYTRUDA", "Merck Sharp & Dohme B.V."},
{"EU/1/15/1023", "Farydak", "Secura Bio Limited"},
{"EU/1/15/1021", "Pregabalin Zentiva", "Zentiva, k.s."},
{"EU/1/15/1020", "Raxone", "Santhera Pharmaceuticals (Deutschland) GmbH"},
{"EU/1/15/1019", "Bortezomib Accord", "Accord Healthcare S.L.U."},
{"EU/1/15/1018", "Omidria", "Omeros Ireland Limited"},
{"EU/1/15/1016", "Repatha", "Amgen Europe B.V."},
{"EU/1/15/1015", "Strensiq", "Alexion Europe SAS"},
{"EU/1/15/1014", "OPDIVO", "Bristol-Myers Squibb Pharma EEIG"},
{"EU/1/15/1013", "Lumark", "IDB Holland B.V."},
{"EU/1/15/1012", "Pregabalin Sandoz GmbH", "Sandoz GmbH"},
{"EU/1/15/1011", "Pregabalin Sandoz", "Sandoz GmbH"},
{"EU/1/15/1010", "Duloxetine Mylan", "Mylan S.A.S."},
{"EU/1/15/1009", "Aripiprazole Zentiva", "Zentiva, k.s."},
{"EU/1/15/1008", "Hetlioz", "Vanda Pharmaceuticals Netherlands B.V.,"},
{"EU/1/15/1007", "Gardasil 9", "MSD VACCINS"},
{"EU/1/15/1006", "Respreeza", "CSL Behring GmbH"},
{"EU/1/15/1005", "Aripiprazole Mylan Pharma", "Mylan S.A.S."},
{"EU/1/15/1004", "Voriconazole Hikma", "Hikma Farmacêutica (Portugal), S.A."},
{"EU/1/15/1003", "Synjardy", "Boehringer Ingelheim International GmbH"},
{"EU/1/15/1002", "Lenvima", "Eisai GmbH"},
{"EU/1/15/1001", "Akynzeo", "Helsinn Birex Pharmaceuticals Ltd"},
{"EU/1/15/1000", "Jinarc", "Otsuka Pharmaceutical Netherlands B.V."},
{"EU/1/15/999", "Zykadia", "Novartis Europharm Limited"},
{"EU/1/15/998", "Pregabalin Mylan Pharma", "Mylan S.A.S."},
{"EU/1/15/997", "Pregabalin Mylan", "Mylan S.A.S."},
{"EU/1/15/994", "Kengrexal", "Chiesi Farmaceutici S.p.A."},
{"EU/1/15/993", "Lixiana", "Daiichi Sankyo Europe GmbH"},
{"EU/1/15/992", "Saxenda", "Novo Nordisk A/S"},
{"EU/1/15/991", "Sivextro", "Merck Sharp & Dohme B.V."},
{"EU/1/15/990", "IKERVIS", "Santen Oy"},
{"EU/1/15/989", "Orbactiv", "Menarini International Operations Luxembourg S.A."},
{"EU/1/14/988", "Mysimba", "Orexigen Therapeutics Ireland Limited"},
{"EU/1/14/987", "Holoclar", "Holostem Terapie Avanzate S.r.l."},
{"EU/1/14/986", "Xydalba", "Allergan Pharmaceuticals International Limited"},
{"EU/1/14/984", "Xadago", "Zambon S.p.A."},
{"EU/1/14/983", "Exviera", "AbbVie Deutschland GmbH & Co. KG"},
{"EU/1/14/982", "Viekirax", "AbbVie Deutschland GmbH & Co. KG"},
{"EU/1/14/981", "Otezla", "Amgen Europe B.V."},
{"EU/1/14/980", "Cosentyx", "Novartis Europharm Limited"},
{"EU/1/14/979", "Ofev", "Boehringer Ingelheim International GmbH"},
{"EU/1/14/978", "Senshio", "Shionogi B.V."},
{"EU/1/14/977", "Rasagiline ratiopharm", "Teva B.V."},
{"EU/1/14/975", "Clopidogrel ratiopharm", "Teva B.V."},
{"EU/1/14/974", "Cerdelga", "Genzyme Europe B.V."},
{"EU/1/14/973", "Quinsair", "Chiesi Farmaceutici S.p.A."},
{"EU/1/14/972", "Duloxetine Lilly", "Eli Lilly Nederland B.V."},
{"EU/1/14/971", "Trevicta", "Janssen-Cilag International NV"},
{"EU/1/14/970", "Rixubis", "Baxalta Innovations GmbH"},
{"EU/1/14/969", "SCENESSE", "Clinuvel Europe Limited"},
{"EU/1/14/967", "Rezolsta", "Janssen-Cilag International NV"},
{"EU/1/14/965", "Ketoconazole HRA", "HRA Pharma Rare Diseases"},
{"EU/1/14/964", "Duaklir Genuair", "AstraZeneca AB"},
{"EU/1/14/963", "Brimica Genuair", "AstraZeneca AB"},
{"EU/1/14/962", "Moventig", "Kyowa Kirin Holdings B.V."},
{"EU/1/14/961", "Tadalafil Mylan", "Mylan S.A.S."},
{"EU/1/14/960", "DUAVIVE", "Pfizer Europe MA EEIG"},
{"EU/1/14/959", "Lynparza", "AstraZeneca AB"},
{"EU/1/14/958", "Harvoni", "Gilead Sciences Ireland UC"},
{"EU/1/14/957", "Cyramza", "Eli Lilly Nederland B.V."},
{"EU/1/14/956", "Trulicity", "Eli Lilly Nederland B.V."},
{"EU/1/14/955", "Lymphoseek", "Navidea Biopharmaceuticals Europe Ltd."},
{"EU/1/14/954", "Vargatef", "Boehringer Ingelheim International GmbH"},
{"EU/1/14/952", "Sevelamer carbonate Winthrop", "Genzyme Europe B.V."},
{"EU/1/14/951", "Busulfan Fresenius Kabi", "Fresenius Kabi Deutschland GmbH"},
{"EU/1/14/947", "Xultophy", "Novo Nordisk A/S"},
{"EU/1/14/946", "Accofil", "Accord Healthcare S.L.U."},
{"EU/1/14/945", "IMBRUVICA", "Janssen-Cilag International NV"},
{"EU/1/14/944", "Abasaglar", "Eli Lilly Nederland B.V."},
{"EU/1/14/943", "Velphoro", "Vifor Fresenius Medical Care Renal Pharma France"},
{"EU/1/14/941", "Vizamyl", "GE Healthcare AS"},
{"EU/1/14/940", "Triumeq", "ViiV Healthcare BV"},
{"EU/1/14/938", "Zydelig", "Gilead Sciences Ireland UC"},
{"EU/1/14/937", "Gazyvaro", "Roche Registration GmbH"},
{"EU/1/14/936", "Nuwiq", "Octapharma AB"},
{"EU/1/14/935", "Envarsus", "Chiesi Farmaceutici S.p.A."},
{"EU/1/14/934", "Plegridy", "Biogen Netherlands B.V."},
{"EU/1/14/933", "Simbrinza", "Novartis Europharm Limited"},
{"EU/1/14/931", "Mekinist", "Novartis Europharm Limited"},
{"EU/1/14/930", "Jardiance", "Boehringer Ingelheim International GmbH"},
{"EU/1/14/929", "Revinty Ellipta", "GlaxoSmithKline (Ireland) Limited"},
{"EU/1/14/928", "Sylvant", "EUSA Pharma (Netherlands) B.V."},
{"EU/1/14/923", "Entyvio", "Takeda Pharma A/S"},
{"EU/1/14/922", "Incruse Ellipta", "GlaxoSmithKline (Ireland) Limited"},
{"EU/1/14/921", "BiResp Spiromax", "Teva Pharma B.V."},
{"EU/1/14/920", "DuoResp Spiromax", "Teva Pharma B.V."},
{"EU/1/14/919", "Hemangiol", "Pierre Fabre Dermatologie"},
{"EU/1/14/918", "Vokanamet", "Janssen-Cilag International NV"},
{"EU/1/14/917", "Ulunar Breezhaler", "Novartis Europharm Limited"},
{"EU/1/14/916", "Pregabalin Pfizer", "Upjohn EESV"},
{"EU/1/14/915", "Ebilfumin", "Actavis Group PTC ehf."},
{"EU/1/14/914", "Vimizim", "BioMarin International Limited"},
{"EU/1/14/913", "Latuda", "Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. S.p.A."},
{"EU/1/13/909", "Bemfola", "Gedeon Richter Plc."},
{"EU/1/13/907", "Adempas", "Bayer AG"},
{"EU/1/13/906", "Neuraceq", "Life Radiopharma Berlin GmbH"},
{"EU/1/13/905", "Izba", "Novartis Europharm Limited"},
{"EU/1/13/904", "Mirvaso", "Galderma International"},
{"EU/1/13/902", "Translarna", "PTC Therapeutics International Limited"},
{"EU/1/13/901", "Sirturo", "Janssen-Cilag International NV"},
{"EU/1/13/900", "Xigduo", "AstraZeneca AB"},
{"EU/1/14/899", "Laventair Ellipta", "GlaxoSmithKline (Ireland) Limited"},
{"EU/1/14/898", "Anoro Ellipta", "GlaxoSmithKline (Ireland) Limited"},
{"EU/1/13/896", "Granupas", "Eurocept International B.V."},
{"EU/1/13/894", "Sovaldi", "Gilead Sciences Ireland UC"},
{"EU/1/13/893", "Opsumit", "Janssen-Cilag International NV"},
{"EU/1/13/892", "Tivicay", "ViiV Healthcare BV"},
{"EU/1/13/891", "Brintellix", "H. Lundbeck A/S"},
{"EU/1/13/890", "Cometriq", "Ipsen Pharma"},
{"EU/1/13/889", "Levetiracetam Hospira", "Pfizer Europe MA EEIG"},
{"EU/1/13/888", "NovoEight", "Novo Nordisk A/S"},
{"EU/1/13/887", "Fluenz Tetra", "AstraZeneca AB"},
{"EU/1/13/886", "Relvar Ellipta", "GlaxoSmithKline (Ireland) Limited"},
{"EU/1/13/885", "Kadcyla", "Roche Registration GmbH"},
{"EU/1/13/884", "Invokana", "Janssen-Cilag International NV"},
{"EU/1/13/882", "ABILIFY MAINTENA", "Otsuka Pharmaceutical Netherlands B.V."},
{"EU/1/13/881", "Fortacin", "Recordati Ireland Ltd"},
{"EU/1/13/880", "Memantine Accord", "Accord Healthcare S.L.U."},
{"EU/1/13/879", "Giotrif", "Boehringer Ingelheim International GmbH"},
{"EU/1/13/878", "Defitelio", "Gentium S.r.I."},
{"EU/1/13/877", "Grastofil", "Accord Healthcare S.L.U."},
{"EU/1/13/875", "Deltyba", "Otsuka Novel Products GmbH"},
{"EU/1/13/873", "Xofigo", "Bayer AG"},
{"EU/1/13/872", "Tybost", "Gilead Sciences Ireland UC"},
{"EU/1/13/871", "Ovaleap", "Theramex Ireland Limited"},
{"EU/1/13/870", "Orphacol", "Laboratoires CTRS"},
{"EU/1/13/869", "Lemtrada", "Sanofi Belgium"},
{"EU/1/13/866", "Cholib", "Mylan IRE Healthcare Ltd"},
{"EU/1/13/865", "Tafinlar", "Novartis Europharm Limited"},
{"EU/1/13/863", "Xoterna Breezhaler", "Novartis Europharm Limited"},
{"EU/1/13/862", "Ultibro Breezhaler", "Novartis Europharm Limited"},
{"EU/1/13/861", "Procysbi", "Chiesi Farmaceutici S.p.A."},
{"EU/1/13/860", "Nexium Control", "GlaxoSmithKline Dungarvan Limited"},
{"EU/1/13/859", "Corbilta", "Orion Corporation"},
{"EU/1/13/858", "Stivarga", "Bayer AG"},
{"EU/1/13/857", "Voncento", "CSL Behring GmbH"},
{"EU/1/13/856", "Lonquex", "Teva B.V."},
{"EU/1/13/855", "Imvanex", "Bavarian Nordic A/S"},
{"EU/1/13/854", "Inflectra", "Pfizer Europe MA EEIG"},
{"EU/1/13/853", "Remsima", "Celltrion Healthcare Hungary Kft."},
{"EU/1/13/852", "Atosiban SUN", "Sun Pharmaceutical Industries Europe BV"},
{"EU/1/13/851", "Lojuxta", "Amryt Pharmaceuticals DAC"},
{"EU/1/13/850", "Imnovid", "Celgene Europe B.V."},
{"EU/1/13/848", "Erivedge", "Roche Registration GmbH"},
{"EU/1/13/846", "Xtandi", "Astellas Pharma Europe B.V."},
{"EU/1/13/845", "Imatinib Accord", "Accord Healthcare S.L.U."},
{"EU/1/13/844", "Vipidia", "Takeda Pharma A/S"},
{"EU/1/13/843", "Vipdomet", "Takeda Pharma A/S"},
{"EU/1/13/842", "Incresync", "Takeda Pharma A/S"},
{"EU/1/13/841", "Spedra", "Menarini International Operations Luxembourg S.A."},
{"EU/1/13/840", "HyQvia", "Baxalta Innovations GmbH"},
{"EU/1/13/839", "Iclusig", "Incyte Biosciences Distribution B.V."},
{"EU/1/13/838", "AUBAGIO", "Sanofi-Aventis groupe"},
{"EU/1/13/837", "Tecfidera", "Biogen Netherlands B.V."},
{"EU/1/13/836", "Memantine ratiopharm", "ratiopharm GmbH"},
{"EU/1/13/835", "Voriconazole Accord", "Accord Healthcare S.L.U."},
{"EU/1/13/834", "Zoledronic acid Accord", "Accord Healthcare S.L.U."},
{"EU/1/13/832", "Stayveer", "Janssen-Cilag International NV"},
{"EU/1/13/830", "Stribild", "Gilead Sciences Ireland UC"},
{"EU/1/13/829", "Hexyon", "Sanofi Pasteur"},
{"EU/1/13/828", "Hexacima", "Sanofi Pasteur"},
{"EU/1/13/827", "Memantine Mylan", "Mylan S.A.S."},
{"EU/1/13/826", "Memantine LEK", "Pharmathen S.A."},
{"EU/1/13/825", "Imatinib Actavis", "Actavis Group PTC ehf."},
{"EU/1/13/824", "Nemdatine", "Actavis Group PTC ehf."},
{"EU/1/13/823", "Adasuve", "Ferrer Internacional S.A."},
{"EU/1/13/822", "PHEBURANE", "Eurocept International BV"},
{"EU/1/13/821", "Tolucombi", "KRKA d d., Novo mesto"},
{"EU/1/13/820", "Marixino", "KRKA d d., Novo mesto"},
{"EU/1/13/819", "JETREA", "Inceptua AB"},
{"EU/1/13/818", "Bosulif", "Pfizer Europe MA EEIG"},
{"EU/1/13/817", "Actelsar HCT", "Actavis Group PTC ehf."},
{"EU/1/12/815", "Selincro", "H. Lundbeck A/S"},
{"EU/1/12/814", "ZALTRAP", "Sanofi-Aventis groupe"},
{"EU/1/13/813", "Perjeta", "Roche Registration GmbH"},
{"EU/1/12/812", "Bexsero", "GlaxoSmithKline Vaccines S.r.l."},
{"EU/1/12/811", "Lyxumia", "Sanofi-Aventis groupe"},
{"EU/1/12/809", "Betmiga", "Astellas Pharma Europe B.V."},
{"EU/1/12/808", "Imatinib Teva", "Teva B.V."},
{"EU/1/12/807", "Tresiba", "Novo Nordisk A/S"},
{"EU/1/12/806", "Ryzodeg", "Novo Nordisk A/S"},
{"EU/1/12/805", "Amyvid", "Eli Lilly Nederland B.V."},
{"EU/1/12/803", "NexoBrid", "MediWound Germany GmbH"},
{"EU/1/12/802", "Capecitabine medac", "medac Gesellschaft für klinische Spezialpräparate mbH"},
{"EU/1/12/801", "Constella", "Allergan Pharmaceuticals International Limited"},
{"EU/1/12/800", "Zoledronic acid Hospira", "Pfizer Europe MA EEIG"},
{"EU/1/12/799", "Memantine Merz", "Merz Pharmaceuticals GmbH"},
{"EU/1/12/798", "Ibandronic acid Accord", "Accord Healthcare S.L.U."},
{"EU/1/12/797", "Eylea", "Bayer AG"},
{"EU/1/12/795", "Forxiga", "AstraZeneca AB"},
{"EU/1/12/794", "ADCETRIS", "Takeda Pharma A/S"},
{"EU/1/12/793", "XALKORI", "Pfizer Europe MA EEIG"},
{"EU/1/12/792", "Dacogen", "Janssen-Cilag International NV"},
{"EU/1/12/790", "Tovanor Breezhaler", "Novartis Europharm Limited"},
{"EU/1/12/789", "Enurev Breezhaler", "Novartis Europharm Limited"},
{"EU/1/12/788", "Seebri Breezhaler", "Novartis Europharm Limited"},
{"EU/1/12/787", "Revestive", "Shire Pharmaceuticals Ireland Limited"},
{"EU/1/12/786", "Zoledronic acid Mylan", "Mylan S.A.S."},
{"EU/1/12/785", "Zinforo", "Pfizer Ireland Pharmaceuticals"},
{"EU/1/12/784", "Cuprymina", "A.C.O.M. -ADVANCED CENTER ONCOLOGY MACERATA -S.R.L."},
{"EU/1/12/783", "Zyclara", "Meda AB"},
{"EU/1/12/782", "Kalydeco", "Vertex Pharmaceuticals (Ireland) Limited"},
{"EU/1/12/781", "Bretaris Genuair", "AstraZeneca AB"},
{"EU/1/12/780", "Jentadueto", "Boehringer Ingelheim International GmbH"},
{"EU/1/12/779", "Zoledronic acid medac", "medac Gesellschaft für klinische Spezialpräparate mbH"},
{"EU/1/12/778", "Eklira Genuair", "AstraZeneca AB"},
{"EU/1/12/777", "Inlyta", "Pfizer Europe MA EEIG"},
{"EU/1/12/776", "Fycompa", "Eisai GmbH"},
{"EU/1/12/775", "NovoThirteen", "Novo Nordisk A/S"},
{"EU/1/12/773", "Jakavi", "Novartis Europharm Limited"},
{"EU/1/12/771", "Zoledronic acid Teva", "Teva B.V."},
{"EU/1/12/770", "Docetaxel Kabi", "Fresenius Kabi Deutschland GmbH"},
{"EU/1/12/769", "Docetaxel Accord", "Accord Healthcare S.L.U."},
{"EU/1/12/768", "Riluzole Zentiva", "Zentiva k.s."},
{"EU/1/12/767", "Nimenrix", "Pfizer Europe MA EEIG"},
{"EU/1/12/766", "SANCUSO", "Kyowa Kirin Holdings B.V."},
{"EU/1/12/764", "Pixuvri", "Les Laboratoires Servier"},
{"EU/1/12/763", "Ecansya", "KRKA d d., Novo mesto"},
{"EU/1/12/762", "Capecitabine Accord", "Accord Healthcare S.L.U."},
{"EU/1/12/761", "Capecitabine Teva", "Teva B.V."},
{"EU/1/12/760", "Bronchitol", "Pharmaxis Europe Limited"},
{"EU/1/12/759", "Zoledronic acid Actavis", "Actavis Group PTC ehf."},
{"EU/1/12/758", "Pioglitazone Teva Pharma", "Teva B.V."},
{"EU/1/12/757", "Pioglitazone Teva", "Teva B.V."},
{"EU/1/12/756", "Glidipion", "Actavis Group PTC ehf."},
{"EU/1/12/755", "Pioglitazone Actavis", "Actavis Group PTC ehf."},
{"EU/1/12/753", "Signifor", "Recordati Rare Diseases"},
{"EU/1/12/751", "Zelboraf", "Roche Registration GmbH"},
{"EU/1/12/750", "Esmya", "Gedeon Richter Plc."},
{"EU/1/11/749", "Caprelsa", "Genzyme Europe B.V."},
{"EU/1/11/747", "Colobreathe", "Teva B.V."},
{"EU/1/11/746", "Desloratadine ratiopharm", "ratiopharm GmbH"},
{"EU/1/11/745", "Desloratadine Actavis", "Actavis Group PTC ehf."},
{"EU/1/11/743", "Repaglinide Accord", "Accord Healthcare S.L.U."},
{"EU/1/11/742", "Efavirenz Teva", "Teva B.V."},
{"EU/1/11/741", "Levetiracetam SUN", "Sun Pharmaceutical Industries Europe BV"},
{"EU/1/11/740", "Ameluz", "Biofrontera Bioscience GmbH"},
{"EU/1/11/739", "Dasselta", "KRKA d d., Novo mesto"},
{"EU/1/11/738", "Levetiracetam Actavis Group", "Actavis Group PTC ehf."},
{"EU/1/11/737", "Eviplera", "Gilead Sciences Ireland UC"},
{"EU/1/11/736", "EDURANT", "Janssen-Cilag International NV"},
{"EU/1/11/734", "Edarbi", "Takeda Pharma A/S"},
{"EU/1/11/733", "Dificlir", "Astellas Pharma Europe B.V."},
{"EU/1/11/732", "Desloratadine Teva", "Teva B.V."},
{"EU/1/11/731", "Komboglyze", "AstraZeneca AB"},
{"EU/1/11/728", "Pramipexole Accord", "Accord Healthcare S.L.U."},
{"EU/1/11/727", "Xaluprine", "Nova Laboratories Ireland Limited"},
{"EU/1/11/722", "Pioglitazone Accord", "Accord Healthcare S.L.U."},
{"EU/1/11/719", "Telmisartan Teva Pharma", "Teva B.V."},
{"EU/1/11/718", "Dexdor", "Orion Corporation"},
{"EU/1/11/717", "Vyndaqel", "Pfizer Europe MA EEIG"},
{"EU/1/11/716", "Eurartesim", "Alfasigma S.p.A."},
{"EU/1/11/715", "Plenadren", "Shire Services BVBA"},
{"EU/1/11/714", "Zytiga", "Janssen-Cilag International NV"},
{"EU/1/11/713", "Levetiracetam Actavis", "Actavis Group PTC ehf."},
{"EU/1/11/712", "Levetiracetam Accord", "Accord Healthcare S.L.U."},
{"EU/1/11/711", "Matever", "Pharmathen S.A."},
{"EU/1/11/710", "Votubia", "Novartis Europharm Limited"},
{"EU/1/11/709", "Buccolam", "Shire Services BVBA"},
{"EU/1/11/708", "Entacapone Orion", "Orion Corporation"},
{"EU/1/11/707", "Trajenta", "Boehringer Ingelheim International GmbH"},
{"EU/1/11/706", "Levodopa/Carbidopa/Entacapone Orion", "Orion Corporation"},
{"EU/1/11/703", "Xgeva", "Amgen Europe B.V."},
{"EU/1/11/702", "Levetiracetam ratiopharm", "ratiopharm GmbH"},
{"EU/1/11/701", "Levetiracetam Teva", "Teva B.V."},
{"EU/1/11/700", "Benlysta", "GlaxoSmithKline (Ireland) Limited"},
{"EU/1/11/699", "Fampyra", "Biogen Netherlands B.V."},
{"EU/1/11/698", "YERVOY", "Bristol-Myers Squibb Pharma EEIG"},
{"EU/1/11/697", "Temozolomide SUN", "Sun Pharmaceutical Industries Europe BV"},
{"EU/1/11/696", "Bydureon", "AstraZeneca AB"},
{"EU/1/11/695", "Leganto", "UCB Pharma S.A."},
{"EU/1/11/694", "NULOJIX", "Bristol-Myers Squibb Pharma EEIG"},
{"EU/1/11/693", "Rivastigmine Actavis", "Actavis Group PTC ehf."},
{"EU/1/11/692", "Yellox", "Bausch Health Ireland Limited"},
{"EU/1/11/691", "Eliquis", "Bristol-Myers Squibb/Pfizer EEIG"},
{"EU/1/11/690", "Zoely", "Theramex Ireland Limited"},
{"EU/1/11/688", "Cinryze", "Shire Services BVBA"},
{"EU/1/11/687", "Hizentra", "CSL Behring GmbH"},
{"EU/1/11/685", "Ibandronic acid Sandoz", "Sandoz GmbH"},
{"EU/1/11/682", "Methylthioninium chloride Proveblue", "Provepharm S.A.S."},
{"EU/1/11/679", "Pravafenix", "LABORATOIRES SMB SA"},
{"EU/1/11/678", "HALAVEN", "Eisai GmbH"},
{"EU/1/11/677", "Gilenya", "Novartis Europharm Limited"},
{"EU/1/11/676", "JEVTANA", "Sanofi-Aventis groupe"},
{"EU/1/11/673", "Ifirmacombi", "KRKA d d., Novo mesto"},
{"EU/1/11/672", "Xeplion", "Janssen-Cilag International NV"},
{"EU/1/11/669", "Teysuno", "Nordic Group B.V."},
{"EU/1/11/667", "Esbriet", "Roche Registration GmbH"},
{"EU/1/10/665", "Entacapone Teva", "Teva B.V."},
{"EU/1/10/663", "Lamivudine / Zidovudine Teva", "Teva B.V."},
{"EU/1/10/660", "Potactasol", "Actavis Group PTC ehf."},
{"EU/1/10/659", "Iasibon", "Pharmathen S.A."},
{"EU/1/10/658", "Aflunov", "Seqirus S.r.l."},
{"EU/1/10/655", "Brilique", "AstraZeneca AB"},
{"EU/1/10/654", "Leflunomide ratiopharm", "ratiopharm GmbH"},
{"EU/1/10/652", "TOBI Podhaler", "Mylan IRE Healthcare Ltd"},
{"EU/1/10/648", "Twynsta", "Boehringer Ingelheim International GmbH"},
{"EU/1/10/647", "Myclausen", "Passauer Pharma GmbH"},
{"EU/1/10/646", "VPRIV", "Shire Pharmaceuticals Ireland Limited"},
{"EU/1/10/645", "Brinavess", "Correvio"},
{"EU/1/10/644", "PecFent", "Kyowa Kirin Holdings B.V."},
{"EU/1/10/643", "Rapiscan", "GE Healthcare AS"},
{"EU/1/10/642", "Ibandronic Acid Teva", "Teva B.V."},
{"EU/1/10/641", "Ruconest", "Pharming Group N.V."},
{"EU/1/10/640", "Sycrest", "Organon N.V."},
{"EU/1/10/639", "Telmisartan Actavis", "Actavis Group PTC ehf."},
{"EU/1/10/638", "Ozurdex", "Allergan Pharmaceuticals Ireland"},
{"EU/1/10/637", "Leflunomide medac", "medac Gesellschaft für klinische Spezialpräparate mbH"},
{"EU/1/10/636", "Daxas", "AstraZeneca AB"},
{"EU/1/10/635", "Olanzapine Apotex", "Apotex Europe B.V."},
{"EU/1/10/633", "Topotecan Hospira", "Pfizer Europe MA EEIG"},
{"EU/1/10/632", "Tolura", "KRKA d d., Novo mesto"},
{"EU/1/10/631", "Nivestim", "Pfizer Europe MA EEIG"},
{"EU/1/10/628", "Votrient", "Novartis Europharm Limited"},
{"EU/1/10/627", "Raloxifene Teva", "Teva B.V."},
{"EU/1/10/622", "Tepadina", "ADIENNE S.r.l."},
{"EU/1/10/621", "Ristaben", "Merck Sharp & Dohme B.V."},
{"EU/1/10/620", "Ristfor", "Merck Sharp & Dohme B.V."},
{"EU/1/10/619", "DuoPlavin", "Sanofi-Aventis groupe"},
{"EU/1/10/618", "Prolia", "Amgen Europe B.V."},
{"EU/1/10/617", "Temozolomide Sandoz", "Sandoz GmbH"},
{"EU/1/10/616", "Temozolomide HEXAL", "Hexal AG"},
{"EU/1/10/615", "Temozolomide Accord", "Accord Healthcare S.L.U."},
{"EU/1/10/614", "Menveo", "GSK Vaccines S.r.l."},
{"EU/1/10/612", "Revolade", "Novartis Europharm Limited"},
{"EU/1/09/611", "Docetaxel Teva", "Teva B.V."},
{"EU/1/09/610", "Telmisartan Teva", "Teva B.V."},
{"EU/1/09/609", "Elonva", "Merck Sharp & Dohme B.V."},
{"EU/1/09/608", "Urorec", "Recordati Ireland Ltd"},
{"EU/1/09/607", "Silodyx", "Recordati Ireland Ltd"},
{"EU/1/09/606", "Temozolomide Teva", "Teva B.V."},
{"EU/1/09/605", "Temomedac", "medac Gesellschaft für klinische Spezialpräparate mbH"},
{"EU/1/09/604", "Leflunomide Zentiva", "Zentiva k.s."},
{"EU/1/09/603", "Sildenafil ratiopharm", "ratiopharm GmbH"},
{"EU/1/09/602", "Scintimun", "CIS bio international"},
{"EU/1/09/601", "Firdapse", "SERB S.A."},
{"EU/1/09/600", "Zutectra", "Biotest Pharma GmbH"},
{"EU/1/09/599", "Rivastigmine Sandoz", "Sandoz GmbH"},
{"EU/1/09/598", "Nevirapine Teva", "Teva B.V."},
{"EU/1/09/597", "Olazax", "Glenmark Pharmaceuticals s.r.o."},
{"EU/1/09/596", "Lamivudine Teva Pharma B.V.", "Teva B.V."},
{"EU/1/09/595", "Sildenafil Actavis", "Actavis Group PTC ehf."},
{"EU/1/09/594", "Hirobriz Breezhaler", "Novartis Europharm Limited"},
{"EU/1/09/593", "Onbrez Breezhaler", "Novartis Europharm Limited"},
{"EU/1/09/592", "Olazax Disperzi", "Glenmark Pharmaceuticals s.r.o."},
{"EU/1/09/591", "Multaq", "Sanofi-Aventis groupe"},
{"EU/1/09/590", "Prevenar 13", "Pfizer Europe MA EEIG"},
{"EU/1/09/589", "Rivastigmine HEXAL", "Hexal AG"},
{"EU/1/09/588", "Olanzapine Glenmark Europe", "Glenmark Arzneimittel GmbH"},
{"EU/1/09/587", "Olanzapine Glenmark", "Glenmark Arzneimittel GmbH"},
{"EU/1/09/586", "Oslif Breezhaler", "Novartis Europharm Limited"},
{"EU/1/09/585", "Rivastigmine 1 A Pharma", "1 A Pharma GmbH"},
{"EU/1/09/584", "Sildenafil Teva", "Teva B.V."},
{"EU/1/09/583", "Irbesartan / Hydrochlorothiazide Teva", "Teva B.V."},
{"EU/1/09/581", "Resolor", "Shire Pharmaceuticals Ireland Limited"},
{"EU/1/09/580", "Enyglid", "KRKA d d., Novo mesto"},
{"EU/1/09/579", "Repaglinide Krka", "KRKA d d., Novo mesto"},
{"EU/1/09/578", "Adjupanrix", "GlaxoSmithKline Biologicals S.A."},
{"EU/1/09/577", "Foclivia", "Seqirus S.r.l.,"},
{"EU/1/09/576", "Irbesartan Teva", "Teva B.V."},
{"EU/1/09/575", "Copalia HCT", "Novartis Europharm Limited"},
{"EU/1/09/574", "Dafiro HCT", "Novartis Europharm Limited"},
{"EU/1/09/573", "Eporatio", "ratiopharm GmbH"},
{"EU/1/09/572", "Vantavo", "Merck Sharp & Dohme B.V."},
{"EU/1/09/571", "Pandemic influenza vaccine H5N1 BAXTER", "Ology Bioservices Ireland LTD"},
{"EU/1/09/569", "Exforge HCT", "Novartis Europharm Limited"},
{"EU/1/09/568", "Clopidogrel Taw Pharma", "Apotex Europe B.V."},
{"EU/1/09/566", "Lamivudine Teva", "Teva B.V."},
{"EU/1/09/565", "Biopoin", "Teva GmbH"},
{"EU/1/09/564", "Ilaris", "Novartis Europharm Limited"},
{"EU/1/09/562", "Clopidogrel Krka d.d.", "KRKA d d., Novo mesto"},
{"EU/1/09/559", "Clopidogrel Mylan", "Mylan S.A.S."},
{"EU/1/09/558", "Clopidogrel BGR", "Laboratoires BIOGARAN"},
{"EU/1/09/556", "Clopidogrel Krka", "KRKA d d., Novo mesto"},
{"EU/1/09/555", "Clopidogrel TAD", "TAD Pharma GmbH"},
{"EU/1/09/553", "Zyllt", "KRKA d d., Novo mesto"},
{"EU/1/09/551", "Vizarsin", "KRKA d d., Novo mesto"},
{"EU/1/09/550", "Javlor", "Pierre Fabre Médicament"},
{"EU/1/09/546", "Simponi", "Janssen Biologics B.V."},
{"EU/1/09/545", "Onglyza", "AstraZeneca AB"},
{"EU/1/09/544", "Cimzia", "UCB Pharma S.A."},
{"EU/1/09/543", "Cayston", "Gilead Sciences Ireland UC"},
{"EU/1/09/540", "Clopidogrel Teva", "Teva B.V."},
{"EU/1/09/539", "Samsca", "Otsuka Pharmaceutical Netherlands B.V."},
{"EU/1/09/538", "Afinitor", "Novartis Europharm Limited"},
{"EU/1/09/537", "Mozobil", "Genzyme Europe B.V."},
{"EU/1/09/535", "Grepid", "Pharmathen S.A."},
{"EU/1/09/533", "Vedrop", "Recordati Rare Diseases"},
{"EU/1/09/531", "Instanyl", "Takeda Pharma A/S"},
{"EU/1/09/530", "Repaglinide Teva", "Teva B.V."},
{"EU/1/09/529", "Victoza", "Novo Nordisk A/S"},
{"EU/1/09/528", "Peyona", "Chiesi Farmaceutici S.p.A."},
{"EU/1/09/527", "Ribavirin Teva Pharma BV", "Teva B.V."},
{"EU/1/09/526", "Iressa", "AstraZeneca AB"},
{"EU/1/09/525", "Nimvastid", "KRKA d d., Novo mesto"},
{"EU/1/09/524", "Qutenza", "Grünenthal GmbH"},
{"EU/1/09/523", "Modigraf", "Astellas Pharma Europe B.V."},
{"EU/1/09/522", "ellaOne", "Laboratoire HRA Pharma"},
{"EU/1/09/521", "Renvela", "Genzyme Europe B.V."},
{"EU/1/09/519", "PANTOLOC Control", "Takeda GmbH"},
{"EU/1/09/517", "PANTOZOL Control", "Takeda GmbH"},
{"EU/1/09/516", "SOMAC Control", "Takeda GmbH"},
{"EU/1/09/515", "CONTROLOC Control", "Takeda GmbH"},
{"EU/1/09/514", "Zebinix", "Bial - Portela & Cª, SA"},
{"EU/1/09/511", "Conbriza", "Pfizer Europe MA EEIG"},
{"EU/1/09/509", "Ribavirin Teva", "Teva B.V."},
{"EU/1/09/508", "Synflorix", "GlaxoSmithKline Biologicals S.A."},
{"EU/1/08/504", "Firmagon", "Ferring Pharmaceuticals A/S"},
{"EU/1/08/503", "Efient", "Daiichi Sankyo Europe GmbH"},
{"EU/1/08/502", "Mepact", "Takeda France SAS"},
{"EU/1/08/501", "Ixiaro", "Valneva Austria GmbH"},
{"EU/1/08/499", "Valdoxan", "Les Laboratoires Servier"},
{"EU/1/08/498", "Thymanax", "Servier (Ireland) Industries Limited"},
{"EU/1/08/497", "Nplate", "Amgen Europe B.V."},
{"EU/1/08/496", "Filgrastim Hexal", "Hexal AG"},
{"EU/1/08/495", "Zarzio", "Sandoz GmbH"},
{"EU/1/08/494", "Stelara", "Janssen-Cilag International NV"},
{"EU/1/08/492", "RoActemra", "Roche Registration GmbH"},
{"EU/1/08/491", "Rasilez HCT", "Noden Pharma DAC"},
{"EU/1/08/490", "Pramipexole Teva", "Teva B.V."},
{"EU/1/08/488", "Vidaza", "Celgene Europe B.V."},
{"EU/1/08/486", "Xiliarx", "Novartis Europharm Limited"},
{"EU/1/08/485", "Jalra", "Novartis Europharm Limited"},
{"EU/1/08/484", "Icandra", "Novartis Europharm Limited"},
{"EU/1/08/483", "Zomarist", "Novartis Europharm Limited"},
{"EU/1/08/482", "Azarga", "Novartis Europharm Limited"},
{"EU/1/08/481", "Kuvan", "BioMarin International Limited"},
{"EU/1/08/480", "Ifirmasta", "KRKA d d., Novo mesto"},
{"EU/1/08/479", "Zypadhera", "Eli Lilly Nederland B.V."},
{"EU/1/08/477", "Ceplene", "Noventia Pharma Srl"},
{"EU/1/08/476", "Adcirca", "Eli Lilly Nederland B.V."},
{"EU/1/08/475", "Olanzapine Mylan", "Mylan S.A.S."},
{"EU/1/08/473", "Evicel", "Omrix Biopharmaceuticals N.V."},
{"EU/1/08/472", "Xarelto", "Bayer AG"},
{"EU/1/08/470", "Vimpat", "UCB Pharma S.A."},
{"EU/1/08/469", "Oprymea", "KRKA d d., Novo mesto"},
{"EU/1/08/468", "Intelence", "Janssen-Cilag International NV"},
{"EU/1/08/466", "Bridion", "Merck Sharp & Dohme B.V."},
{"EU/1/08/465", "Clopidogrel Zentiva", "Zentiva, k.s."},
{"EU/1/08/463", "Relistor", "Bausch Health Ireland Limited"},
{"EU/1/08/462", "Ranexa", "Menarini International Operations Luxembourg S.A."},
{"EU/1/08/461", "Firazyr", "Shire Pharmaceuticals Ireland Limited"},
{"EU/1/08/457", "Efficib", "Merck Sharp & Dohme B.V."},
{"EU/1/08/456", "Velmetia", "Merck Sharp & Dohme B.V."},
{"EU/1/08/455", "Janumet", "Merck Sharp & Dohme B.V."},
{"EU/1/08/454", "Extavia", "Novartis Europharm Limited"},
{"EU/1/08/451", "Volibris", "GlaxoSmithKline (Ireland) Limited"},
{"EU/1/08/448", "Mycamine", "Astellas Pharma Europe B.V."},
{"EU/1/08/447", "Adenuric", "Menarini International Operations Luxembourg S.A."},
{"EU/1/08/446", "Privigen", "CSL Behring GmbH"},
{"EU/1/08/445", "Tevagrastim", "Teva GmbH"},
{"EU/1/08/444", "Ratiograstim", "ratiopharm GmbH"},
{"EU/1/08/443", "Thalidomide Celgene", "Celgene Europe B.V."},
{"EU/1/08/442", "Pradaxa", "Boehringer Ingelheim International GmbH"},
{"EU/1/08/441", "Effentora", "Teva B.V."},
{"EU/1/07/440", "Tyverb", "Novartis Europharm Limited"},
{"EU/1/07/439", "Mycophenolate mofetil Teva", "Teva B.V."},
{"EU/1/07/438", "Myfenax", "Teva B.V."},
{"EU/1/07/437", "Ivemend", "Merck Sharp & Dohme B.V."},
{"EU/1/07/436", "Isentress", "Merck Sharp & Dohme B.V."},
{"EU/1/07/435", "Tesavel", "Merck Sharp & Dohme B.V."},
{"EU/1/07/434", "Avamys", "GlaxoSmithKline (Ireland) Limited"},
{"EU/1/07/433", "Nevanac", "Novartis Europharm Limited"},
{"EU/1/07/432", "Silapo", "STADA Arzneimittel AG"},
{"EU/1/07/431", "Retacrit", "Pfizer Europe MA EEIG"},
{"EU/1/07/430", "Atripla", "Gilead Sciences Ireland UC"},
{"EU/1/07/428", "Abraxane", "Celgene Europe B.V."},
{"EU/1/07/427", "Olanzapine Teva", "Teva B.V."},
{"EU/1/07/425", "Eucreas", "Novartis Europharm Limited"},
{"EU/1/07/424", "Torisel", "Pfizer Europe MA EEIG"},
{"EU/1/07/423", "Vectibix", "Amgen Europe B.V."},
{"EU/1/07/422", "Tasigna", "Novartis Europharm Limited"},
{"EU/1/07/421", "Glubrava", "Takeda Pharma A/S"},
{"EU/1/07/420", "Cyanokit", "SERB S.A."},
{"EU/1/07/419", "Cervarix", "GlaxoSmithKline Biologicals S.A."},
{"EU/1/07/418", "Celsentri", "ViiV Healthcare BV"},
{"EU/1/07/417", "Yondelis", "Pharma Mar S.A."},
{"EU/1/07/416", "Ecalta", "Pfizer Europe MA EEIG"},
{"EU/1/07/415", "Zalasta", "KRKA d d., Novo mesto"},
{"EU/1/07/414", "Galvus", "Novartis Europharm Limited"},
{"EU/1/07/413", "Gliolan", "medac Gesellschaft für klinische Spezialpräparate mbH"},
{"EU/1/07/412", "Abseamed", "Medice Arzneimittel Pütter GmbH & Co KG"},
{"EU/1/07/411", "Epoetin alfa Hexal", "Hexal AG"},
{"EU/1/07/410", "Binocrit", "Sandoz GmbH"},
{"EU/1/07/405", "Rasilez", "Noden Pharma DAC"},
{"EU/1/07/404", "Flebogamma DIF", "Instituto Grifols, S.A."},
{"EU/1/07/403", "Atriance", "Novartis Europharm Limited"},
{"EU/1/07/402", "INCRELEX", "Ipsen Pharma"},
{"EU/1/07/401", "alli", "GlaxoSmithKline Dungarvan Limited"},
{"EU/1/07/400", "Mircera", "Roche Registration GmbH"},
{"EU/1/07/399", "Aerinaze", "Merck Sharp & Dohme B.V."},
{"EU/1/07/397", "Siklos", "Addmedica"},
{"EU/1/07/396", "Pergoveris", "Merck Europe B.V."},
{"EU/1/07/395", "Invega", "Janssen-Cilag International NV"},
{"EU/1/07/393", "Soliris", "Alexion Europe SAS"},
{"EU/1/07/392", "Circadin", "RAD Neurim Pharmaceuticals EEC SARL"},
{"EU/1/07/391", "Revlimid", "Bristol-Myers Squibb Pharma EEIG"},
{"EU/1/07/389", "Orencia", "Bristol-Myers Squibb Pharma EEIG"},
{"EU/1/07/388", "Sebivo", "Novartis Europharm Limited"},
{"EU/1/07/387", "Advagraf", "Astellas Pharma Europe B.V."},
{"EU/1/07/386", "Toviaz", "Pfizer Europe MA EEIG"},
{"EU/1/07/384", "Docetaxel Zentiva", "Zentiva k.s."},
{"EU/1/07/383", "Januvia", "Merck Sharp & Dohme B.V."},
{"EU/1/07/382", "Xelevia", "Merck Sharp & Dohme B.V."},
{"EU/1/06/380", "PREZISTA", "Janssen-Cilag International NV"},
{"EU/1/06/379", "Cystadane", "Recordati Rare Diseases"},
{"EU/1/06/378", "Inovelon", "Eisai GmbH"},
{"EU/1/06/377", "Irbesartan HCT Zentiva", "Zentiva k.s."},
{"EU/1/06/376", "Irbesartan Zentiva", "Zentiva k.s."},
{"EU/1/06/374", "Lucentis", "Novartis Europharm Limited"},
{"EU/1/06/372", "Copalia", "Novartis Europharm Limited"},
{"EU/1/06/371", "Dafiro", "Novartis Europharm Limited"},
{"EU/1/06/370", "Exforge", "Novartis Europharm Limited"},
{"EU/1/06/367", "Diacomit", "Biocodex"},
{"EU/1/06/366", "Tandemact", "Takeda Pharma A/S"},
{"EU/1/06/365", "Elaprase", "Shire Human Genetic Therapies AB"},
{"EU/1/06/364", "Adrovance", "Merck Sharp & Dohme B.V."},
{"EU/1/06/363", "Sprycel", "Bristol-Myers Squibb Pharma EEIG"},
{"EU/1/06/362", "Byetta", "AstraZeneca AB"},
{"EU/1/06/361", "Luminity", "Lantheus EU Limited"},
{"EU/1/06/360", "Champix", "Pfizer Europe MA EEIG"},
{"EU/1/06/359", "Suboxone", "Indivior Europe Limited"},
{"EU/1/06/357", "Gardasil", "MSD VACCINS"},
{"EU/1/06/356", "Exjade", "Novartis Europharm Limited"},
{"EU/1/06/354", "Competact", "Takeda Pharma A/S"},
{"EU/1/06/350", "Savene", "Clinigen Healthcare B.V."},
{"EU/1/06/348", "RotaTeq", "MSD VACCINS"},
{"EU/1/06/347", "Sutent", "Pfizer Europe MA EEIG"},
{"EU/1/06/346", "Tysabri", "Biogen Netherlands B.V."},
{"EU/1/06/343", "Baraclude", "Bristol-Myers Squibb Pharma EEIG"},
{"EU/1/06/342", "Nexavar", "Bayer AG"},
{"EU/1/06/341", "Zostavax", "MSD VACCINS"},
{"EU/1/06/340", "Ganfort", "Allergan Pharmaceuticals Ireland"},
{"EU/1/06/338", "DuoTrav", "Novartis Europharm Limited"},
{"EU/1/06/337", "M-M-RVAXPRO", "MSD VACCINS"},
{"EU/1/06/336", "Tygacil", "Pfizer Europe MA EEIG"},
{"EU/1/06/334", "Evoltra", "Genzyme Europe B.V."},
{"EU/1/06/333", "Myozyme", "Genzyme Europe B.V."},
{"EU/1/06/332", "Omnitrope", "Sandoz GmbH"},
{"EU/1/05/331", "Neupro", "UCB Pharma S.A."},
{"EU/1/05/330", "Rotarix", "GlaxoSmithKline Biologicals S.A."},
{"EU/1/05/329", "Kiovig", "Takeda Manufacturing Austria AG"},
{"EU/1/05/328", "Cubicin", "Merck Sharp & Dohme B.V."},
{"EU/1/05/324", "Naglazyme", "BioMarin International Limited"},
{"EU/1/05/323", "ProQuad", "MSD VACCINS"},
{"EU/1/05/322", "Yttriga", "Eckert & Ziegler Radiopharma GmbH"},
{"EU/1/05/320", "Noxafil", "Merck Sharp & Dohme B.V."},
{"EU/1/05/319", "Xolair", "Novartis Europharm Limited"},
{"EU/1/05/318", "Revatio", "Upjohn EESV"},
{"EU/1/05/317", "Corlentor", "Les Laboratoires Servier"},
{"EU/1/05/316", "Procoralan", "Les Laboratoires Servier"},
{"EU/1/05/315", "APTIVUS", "Boehringer Ingelheim International GmbH"},
{"EU/1/05/312", "Xyrem", "UCB Pharma S.A."},
{"EU/1/05/311", "Tarceva", "Roche Registration GmbH"},
{"EU/1/05/310", "Fosavance", "Merck Sharp & Dohme B.V."},
{"EU/1/05/308", "Aclasta", "Novartis Europharm Limited"},
{"EU/1/04/307", "Zonegran", "Eisai GmbH"},
{"EU/1/04/306", "Aloxi", "Helsinn Birex Pharmaceuticals Ltd"},
{"EU/1/04/305", "Truvada", "Gilead Sciences Ireland UC"},
{"EU/1/04/304", "Azilect", "Teva B.V."},
{"EU/1/04/303", "Orfadin", "Swedish Orphan Biovitrum International AB"},
{"EU/1/04/302", "Prialt", "RIEMSER Pharma GmbH"},
{"EU/1/04/300", "Avastin", "Roche Registration GmbH"},
{"EU/1/04/299", "Fendrix", "GlaxoSmithKline Biologicals S.A."},
{"EU/1/04/298", "Kivexa", "ViiV Healthcare BV"},
{"EU/1/04/297", "Nodetrip", "Esteve Pharmaceuticals S.A."},
{"EU/1/04/296", "Cymbalta", "Eli Lilly Nederland B.V."},
{"EU/1/04/295", "Xagrid", "Shire Pharmaceuticals Ireland Limited"},
{"EU/1/04/294", "Emselex", "Merus Labs Luxco II S.à R.L."},
{"EU/1/04/292", "Mimpara", "Amgen Europe B.V."},
{"EU/1/04/290", "Alimta", "Eli Lilly Nederland B.V."},
{"EU/1/04/286", "Wilzin", "Recordati Rare Diseases"},
{"EU/1/04/285", "Apidra", "Sanofi-Aventis Deutschland GmbH"},
{"EU/1/04/284", "Pedea", "Recordati Rare Diseases"},
{"EU/1/04/282", "Telzir", "ViiV Healthcare BV"},
{"EU/1/04/281", "Erbitux", "Merck Europe B.V."},
{"EU/1/04/280", "Yentreve", "Eli Lilly Nederland B.V."},
{"EU/1/04/279", "Lyrica", "Upjohn EESV"},
{"EU/1/04/278", "Levemir", "Novo Nordisk A/S"},
{"EU/1/04/277", "TachoSil", "Takeda Austria GmbH"},
{"EU/1/04/276", "Abilify", "Otsuka Pharmaceutical Netherlands B.V."},
{"EU/1/04/275", "Litak", "Lipomed GmbH"},
{"EU/1/04/274", "VELCADE", "Janssen-Cilag International NV"},
{"EU/1/04/273", "Lysodren", "HRA Pharma Rare Diseases"},
{"EU/1/03/271", "Advate", "Takeda Manufacturing Austria AG"},
{"EU/1/03/270", "Kentera", "Teva B.V."},
{"EU/1/03/269", "Faslodex", "AstraZeneca AB"},
{"EU/1/03/268", "Cholestagel", "Genzyme Europe B.V."},
{"EU/1/03/267", "Reyataz", "Bristol-Myers Squibb Pharma EEIG"},
{"EU/1/03/265", "Bonviva", "Atnahs Pharma Netherlands B.V."},
{"EU/1/03/264", "Zevalin", "Ceft Biopharma s.r.o"},
{"EU/1/03/263", "Dukoral", "Valneva Sweden AB"},
{"EU/1/03/262", "Emend", "Merck Sharp & Dohme B.V."},
{"EU/1/03/261", "Emtriva", "Gilead Sciences Ireland UC"},
{"EU/1/03/260", "Stalevo", "Orion Corporation"},
{"EU/1/03/256", "Humira", "AbbVie Deutschland GmbH & Co. KG"},
{"EU/1/03/255", "Ventavis", "Bayer AG"},
{"EU/1/03/254", "Busilvex", "Pierre Fabre Médicament"},
{"EU/1/03/253", "Aldurazyme", "Genzyme Europe B.V."},
{"EU/1/03/252", "Fuzeon", "Roche Registration GmbH"},
{"EU/1/03/251", "Hepsera", "Gilead Sciences Ireland UC"},
{"EU/1/03/250", "Ytracis", "CIS bio international"},
{"EU/1/03/249", "Vivanza", "Bayer AG"},
{"EU/1/03/248", "Levitra", "Bayer AG"},
{"EU/1/03/247", "Forsteo", "Eli Lilly Nederland B.V."},
{"EU/1/02/246", "Carbaglu", "Recordati Rare Diseases"},
{"EU/1/02/240", "Somavert", "Pfizer Europe MA EEIG"},
{"EU/1/02/238", "Zavesca", "Janssen-Cilag International NV"},
{"EU/1/02/237", "Cialis", "Eli Lilly Nederland B.V."},
{"EU/1/02/234", "Protaphane", "Novo Nordisk A/S"},
{"EU/1/02/233", "Insulatard", "Novo Nordisk A/S"},
{"EU/1/02/231", "Mixtard", "Novo Nordisk A/S"},
{"EU/1/02/230", "Actrapid", "Novo Nordisk A/S"},
{"EU/1/02/229", "Actraphane", "Novo Nordisk A/S"},
{"EU/1/02/227", "Neulasta", "Amgen Europe B.V."},
{"EU/1/02/226", "InductOs", "Medtronic BioPharma B.V."},
{"EU/1/02/224", "Ambirix", "GlaxoSmithKline Biologicals S.A."},
{"EU/1/02/223", "Evra", "Janssen-Cilag International NV"},
{"EU/1/02/222", "Tamiflu", "Roche Registration GmbH"},
{"EU/1/02/221", "Pegasys", "Roche Registration GmbH"},
{"EU/1/02/220", "Tracleer", "Janssen-Cilag International NV"},
{"EU/1/02/219", "Ebixa", "H. Lundbeck A/S"},
{"EU/1/02/218", "Axura", "Merz Pharmaceuticals GmbH"},
{"EU/1/02/217", "Opatanol", "Novartis Europharm Limited"},
{"EU/1/02/216", "Invanz", "Merck Sharp & Dohme B.V."},
{"EU/1/02/215", "PritorPlus", "Bayer AG"},
{"EU/1/02/214", "Kinzalkomb", "Bayer AG"},
{"EU/1/02/213", "MicardisPlus", "Boehringer Ingelheim International GmbH"},
{"EU/1/02/212", "Vfend", "Pfizer Europe MA EEIG"},
{"EU/1/02/209", "Dynastat", "Pfizer Europe MA EEIG"},
{"EU/1/02/206", "Arixtra", "Aspen Pharma Trading Limited"},
{"EU/1/02/205", "Lumigan", "Allergan Pharmaceuticals Ireland"},
{"EU/1/02/204", "TRISENOX", "Teva B.V."},
{"EU/1/02/203", "Kineret", "Swedish Orphan Biovitrum AB (publ)"},
{"EU/1/02/201", "Protopic", "Leo Pharma A/S"},
{"EU/1/01/200", "Viread", "Gilead Sciences Ireland UC"},
{"EU/1/01/199", "Travatan", "Novartis Europharm Limited"},
{"EU/1/01/198", "Glivec", "Novartis Europharm Limited"},
{"EU/1/01/197", "Foscan", "biolitec Pharma Ltd"},
{"EU/1/01/196", "CANCIDAS", "Merck Sharp & Dohme B.V."},
{"EU/1/01/195", "Liprolog", "Eli Lilly Nederland B.V."},
{"EU/1/01/194", "INOmax", "Linde Healthcare AB"},
{"EU/1/01/190", "Ceprotin", "Takeda Manufacturing Austria AG"},
{"EU/1/01/189", "Replagal", "Shire Human Genetic Therapies AB"},
{"EU/1/01/188", "Fabrazyme", "Genzyme Europe B.V."},
{"EU/1/01/185", "Aranesp", "Amgen Europe B.V."},
{"EU/1/01/183", "HBVAXPRO", "MSD VACCINS"},
{"EU/1/01/178", "Targretin", "Eisai GmbH"},
{"EU/1/01/177", "SonoVue", "Bracco International B.V."},
{"EU/1/01/176", "Zometa", "Novartis Europharm Limited"},
{"EU/1/01/174", "Starlix", "Novartis Europharm Limited"},
{"EU/1/01/173", "Vaniqa", "Almirall, S.A."},
{"EU/1/01/172", "Kaletra", "AbbVie Deutschland GmbH & Co. KG"},
{"EU/1/01/171", "Rapamune", "Pfizer Europe MA EEIG"},
{"EU/1/00/170", "Fasturtec", "Sanofi-Aventis groupe"},
{"EU/1/00/169", "Metalyse", "Boehringer Ingelheim International GmbH"},
{"EU/1/00/166", "NeuroBloc", "Sloan Pharma S.a.r.l."},
{"EU/1/00/165", "Ovitrelle", "Merck Europe B.V."},
{"EU/1/00/164", "NutropinAq", "Ipsen Pharma"},
{"EU/1/00/163", "Xeloda", "Roche Registration GmbH"},
{"EU/1/00/162", "Prandin", "Novo Nordisk A/S"},
{"EU/1/00/161", "Neoclarityn", "Merck Sharp & Dohme B.V."},
{"EU/1/00/160", "Aerius", "Merck Sharp & Dohme B.V."},
{"EU/1/00/157", "Azomyr", "Merck Sharp & Dohme B.V."},
{"EU/1/00/156", "Trizivir", "ViiV Healthcare BV"},
{"EU/1/00/155", "Luveris", "Merck Europe B.V."},
{"EU/1/00/152", "Infanrix hexa", "GlaxoSmithKline Biologicals S.A."},
{"EU/1/00/151", "Glustin", "Takeda Pharma A/S"},
{"EU/1/00/150", "Actos", "Takeda Pharma A/S"},
{"EU/1/00/149", "Panretin", "Amdipharm Limited"},
{"EU/1/00/146", "Keppra", "UCB Pharma S.A."},
{"EU/1/00/145", "Herceptin", "Roche Registration GmbH"},
{"EU/1/00/143", "KOGENATE Bayer", "Bayer AG"},
{"EU/1/00/142", "NovoMix", "Novo Nordisk A/S"},
{"EU/1/00/141", "Myocet liposomal", "Teva B.V."},
{"EU/1/00/140", "Visudyne", "CHEPLAPHARM Arzneimittel GmbH"},
{"EU/1/00/135", "DaTSCAN", "GE Healthcare B.V."},
{"EU/1/00/134", "Lantus", "Sanofi-Aventis Deutschland GmbH"},
{"EU/1/00/133", "Toujeo", "Sanofi-Aventis Deutschland GmbH"},
{"EU/1/00/131", "PegIntron", "Merck Sharp & Dohme B.V."},
{"EU/1/00/130", "Orgalutran", "Merck Sharp & Dohme B.V."},
{"EU/1/00/129", "Azopt", "Novartis Europharm Limited"},
{"EU/1/99/127", "IntronA", "Merck Sharp & Dohme B.V."},
{"EU/1/99/126", "Enbrel", "Pfizer Europe MA EEIG"},
{"EU/1/99/125", "Zyprexa Velotab", "Eli Lilly Nederland B.V."},
{"EU/1/99/124", "Tractocile", "Ferring Pharmaceuticals A/S"},
{"EU/1/99/123", "Renagel", "Genzyme Europe B.V."},
{"EU/1/99/122", "Thyrogen", "Genzyme Europe B.V."},
{"EU/1/99/120", "Ammonaps", "Immedica Pharma AB"},
{"EU/1/99/119", "NovoRapid", "Novo Nordisk A/S"},
{"EU/1/99/118", "Arava", "Sanofi-Aventis Deutschland GmbH"},
{"EU/1/99/117", "Synagis", "AbbVie Deutschland GmbH & Co. KG"},
{"EU/1/99/116", "Remicade", "Janssen Biologics B.V."},
{"EU/1/99/114", "Zeffix", "GlaxoSmithKline (Ireland) Limited"},
{"EU/1/99/112", "Ziagen", "ViiV Healthcare BV"},
{"EU/1/99/111", "Stocrin", "Merck Sharp & Dohme B.V."},
{"EU/1/99/110", "Sustiva", "Bristol-Myers Squibb Pharma EEIG"},
{"EU/1/99/109", "Integrilin", "GlaxoSmithKline (Ireland) Limited"},
{"EU/1/99/108", "Ferriprox", "Chiesi Farmaceutici S.p.A."},
{"EU/1/99/107", "Rebetol", "Merck Sharp & Dohme B.V."},
{"EU/1/99/103", "ReFacto AF", "Pfizer Europe MA EEIG"},
{"EU/1/99/100", "Cetrotide", "Merck Europe B.V."},
{"EU/1/99/097", "Beromun", "BELPHARMA s.a."},
{"EU/1/98/096", "Temodal", "Merck Sharp & Dohme B.V."},
{"EU/1/98/095", "Emadine", "Novartis Europharm Limited"},
{"EU/1/98/092", "Prometax", "Novartis Europharm Limited"},
{"EU/1/98/091", "Kinzalmono", "Bayer AG"},
{"EU/1/98/090", "Micardis", "Boehringer Ingelheim International GmbH"},
{"EU/1/98/089", "Pritor", "Bayer AG"},
{"EU/1/98/086", "CoAprovel", "Sanofi-Aventis groupe"},
{"EU/1/98/085", "Karvezide", "Sanofi-Aventis groupe"},
{"EU/1/98/084", "Simulect", "Novartis Europharm Limited"},
{"EU/1/98/082", "Comtess", "Orion Corporation"},
{"EU/1/98/081", "Comtan", "Orion Corporation"},
{"EU/1/98/080", "Aldara", "Meda AB"},
{"EU/1/98/077", "Viagra", "Upjohn EESV"},
{"EU/1/98/076", "NovoNorm", "Novo Nordisk A/S"},
{"EU/1/98/074", "Optruma", "Eli Lilly Nederland B.V."},
{"EU/1/98/073", "Evista", "SUBSTIPHARM"},
{"EU/1/98/071", "Xenical", "CHEPLAPHARM Arzneimittel GmbH"},
{"EU/1/98/070", "Iscover", "Sanofi-Aventis groupe"},
{"EU/1/98/069", "Plavix", "Sanofi-Aventis groupe"},
{"EU/1/98/067", "Mabthera", "Roche Registration GmbH"},
{"EU/1/98/066", "Exelon", "Novartis Europharm Limited"},
{"EU/1/98/065", "Optison", "GE Healthcare AS"},
{"EU/1/98/064", "Pylobactell", "Torbet Laboratories Ireland Limited"},
{"EU/1/98/063", "Rebif", "Merck Europe B.V."},
{"EU/1/98/058", "Combivir", "ViiV Healthcare BV"},
{"EU/1/97/057", "Quadramet", "CIS bio international"},
{"EU/1/97/055", "Viramune", "Boehringer Ingelheim International GmbH"},
{"EU/1/97/053", "Cerezyme", "Genzyme Europe B.V."},
{"EU/1/97/051", "Mirapexin", "Boehringer Ingelheim International GmbH"},
{"EU/1/97/050", "Sifrol", "Boehringer Ingelheim International GmbH"},
{"EU/1/97/049", "Karvea", "Sanofi-Aventis groupe"},
{"EU/1/97/047", "BeneFIX", "Pfizer Europe MA EEIG"},
{"EU/1/97/046", "Aprovel", "Sanofi-Aventis groupe"},
{"EU/1/97/045", "Helicobacter Test INFAI", "INFAI GmbH"},
{"EU/1/97/044", "Tasmar", "Meda AB"},
{"EU/1/97/039", "Cystagon", "Recordati Rare Diseases"},
{"EU/1/97/033", "Avonex", "Biogen Netherlands B.V."},
{"EU/1/97/031", "NeoRecormon", "Roche Registration GmbH"},
{"EU/1/97/030", "Insuman", "Sanofi-Aventis Deutschland GmbH"},
{"EU/1/97/029", "Twinrix Paediatric", "GlaxoSmithKline Biologicals S.A."},
{"EU/1/96/027", "Hycamtin", "Novartis Europharm Limited"},
{"EU/1/96/026", "Invirase", "Roche Registration GmbH"},
{"EU/1/96/024", "Crixivan", "Merck Sharp & Dohme B.V."},
{"EU/1/96/022", "Zyprexa", "Eli Lilly Nederland B.V."},
{"EU/1/96/020", "Twinrix Adult", "GlaxoSmithKline Biologicals S.A."},
{"EU/1/96/018", "Rapilysin", "Actavis Group PTC ehf."},
{"EU/1/96/016", "Norvir", "AbbVie Deutschland GmbH & Co. KG"},
{"EU/1/96/015", "Epivir", "ViiV Healthcare B.V."},
{"EU/1/96/012", "Bondronat", "Copenhagen Towers, Ørestads Boulevard 108, 5.tv, DK-2300 København S, Danmark"},
{"EU/1/96/011", "Caelyx pegylated liposomal", "Janssen-Cilag International NV"},
{"EU/1/96/010", "Rilutek", "Sanofi Mature IP"},
{"EU/1/96/008", "Puregon", "Merck Sharp & Dohme B.V."},
{"EU/1/96/007", "Humalog", "Eli Lilly Nederland B.V."},
{"EU/1/96/006", "NovoSeven", "Novo Nordisk A/S"},
{"EU/1/96/005", "CellCept", "Roche Registration GmbH"},
{"EU/1/96/004", "Fareston", "Orion Corporation"},
{"EU/1/95/003", "Betaferon", "Bayer AG"},
{"EU/1/95/002", "Taxotere", "Sanofi Mature IP"},
{"EU/1/95/001", "GONAL-f", "Merck Europe B.V."},
}
local function cleanup(txt)
return mw.text.trim(txt:gsub("%([^)]*%)", "")):lower()
end
local p = {}
p.id = {}
for idx, dat in ipairs(eurmpdata) do
local pname = cleanup(dat[2])
p.id[pname] = dat[1]
end
return p
